UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~June 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to________

Commission File No. 001-39338

NUZEE, INC.

(exact name of registrant as specified in its charter)

Nevada

38-3849791

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

1401 Capital Avenue, Suite B, Plano, TX, 75074

(Address of principal executive offices) (zip code)

(760) 295-2408

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Stock, $0.00001 par value		NUZE		TheNASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated Filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~May 12,~~August 11, 2022, the registrant had ~~19,461,139~~23,668,017 shares of common stock outstanding.

Table of Contents

	Page

PART I

Item 1. Financial Statements	45
Consolidated Balance Sheets (unaudited)	45
Consolidated Statements of Operations (unaudited)	56
Consolidated Statements of Comprehensive Income (Loss) (unaudited)	67
Consolidated Statements of Stockholders’ Equity (unaudited)	78
Consolidated Statements of Cash Flows (unaudited)	810
Notes to Consolidated Financial Statements (unaudited)	911
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	2022
Item 3. Quantitative and Qualitative Disclosures About Market Risk	2629
Item 4. Controls and Procedures	2629

PART II	2730

Item 1. Legal Proceedings	2730
Item 1A. Risk Factors	2730
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	2830
~~Item 5. Other Items~~	28
Item 6. Exhibits	2931
SIGNATURES	3032

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

This report includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Such forward-looking statements reflect the views of NuZee, Inc. (“NuZee” or the “Company”) with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. From time to time, our management or persons acting on our behalf may make forward-looking statements to inform existing and potential security holders about the Company. All statements other than statements of historical facts included in this report regarding our financial position, business strategy, plans and objectives of management for future operations, industry conditions, or any other matters, are forward-looking statements. When used in this report, forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “expects”, “project,” “predict,” “believe,” “expect,” “anticipate,” “target,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about, actual or potential future sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Forward-looking statements in this report may include, without limitation, statements regarding:

	●	our plans to obtain funding for our operations, including funding necessary to develop, manufacture and commercialize our products and provide our co-packing services;

	●	the impact to our business from the COVID-19 global crisis, including any supply chain interruptions;

	●	the evolving coffee preferences of coffee consumers in North America and Korea;

	●	the size and growth of the markets for our products and co-packing services;

	●	our ability to compete with companies producing similar products or providing similar co-packing services;

	●	our expectation that our existing capital resources will be sufficient to fund our operations for at least the next 12 months;

	●	our ability to successfully achieve the anticipated results of strategic transactions, including our acquisition of substantially all of the assets of Dripkit (as defined below);

	●	our expectation regarding our future co-packing revenues;

	●	our ability to develop innovative new products and expand our co-packing services to other products that are complementary to our current single serve coffee product offerings;

	●	our reliance on third-party roasters to roast coffee beans necessary to manufacture our products and fulfill every aspect of our co-packing services;

	●	regulatory developments in the U.S. and in non-U.S. countries;

	●	our ability to retain key management, sales, and marketing personnel;

	●	the scope of protection we are able to establish and maintain for intellectual property rights covering our products and technology;

	●	the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;

	●	our ability to develop and maintain our corporate infrastructure, including our internal control over financial reporting;

	●	the outcome of pending, threatened or future litigation; and

	●	our financial performance.

The forward-looking statements are not meant to predict or guarantee actual results, performance, events, or circumstances and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which we have no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Forward-looking statements speak only as of the date they are made. You should consider carefully the statements in the section of our Annual Report on Form 10-K filed with the SEC on December 22, 2021, titled “Risk Factors” and sections of this report that describe factors that could cause our actual results to differ from those set forth in the forward-looking statements.

Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

Item 1. Financial Statements

NuZee, Inc.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

March 31, 2022 September 30, 2021
ASSETS
Current assets:
Cash $ 8,211,703 $ 10,815,954
Accounts receivable, net 646,886 555,238
Inventories, net 631,284 573,464
Prepaid expenses and other current assets 1,012,441 482,288
Total current assets 10,502,314 12,426,944

Property and equipment, net 672,645 674,024

Other assets:
Right-of-use asset - operating lease 850,414 386,587
Investment 173,129 175,425
Goodwill 531,412 -
Intangible assets, net 323,389 -
Other assets 105,349 79,822
Total other assets 1,983,693 641,834

Total assets $ 13,158,652 $ 13,742,802

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 839,121 $ 342,790
Current portion of long-term loan payable 19,519 43,618
Current portion of lease liability - operating lease 349,825 150,931
Current portion of lease liability - finance lease 29,665 27,833
Accrued expenses 177,089 274,009
Deferred income 289,031 175,822
Other current liabilities 45,922 138,631
Advances received on sale of equity securities 300,000 -
Total current liabilities 2,050,172 1,153,634

Non-current liabilities:
Lease liability - operating lease, net of current portion 515,608 247,656
Lease liability - finance lease, net of current portion 36,865 50,567
Loan payable - long term, net of current portion 8,748 12,696
Other noncurrent liabilities 77,429 65,802
Total non-current liabilities 638,650 376,721

Total liabilities $ 2,688,822 $ 1,530,355

Stockholders’ equity:
Common stock; 100,000,000 shares authorized, $0.00001 par value; 18,557,886 and 17,820,390 shares issued and outstanding as of March 31, 2022, and September 30, 2021, respectively $ 185 $ 178
Additional paid in capital 69,098,937 64,839,254
Accumulated deficit (58,852,708 ) (52,824,808 )
Accumulated other comprehensive income 223,416 197,823
Total stockholders’ equity 10,469,830 12,212,447

Total liabilities and stockholders’ equity $ 13,158,652 $ 13,742,802
~~The accompanying notes are an integral part of these unaudited consolidated financial statements.~~
4
~~NuZee, Inc.~~
~~CONSOLIDATED STATEMENTS OF OPERATIONS~~
~~(UNAUDITED)~~
June 30, 2022 September 30, 2021
ASSETS
Current assets:
Cash $ 7,523,099 $ 10,815,954
Accounts receivable, net 573,990 555,238
Inventories, net 682,580 573,464
Prepaid expenses and other current assets 1,174,297 482,288
Total current assets 9,953,966 12,426,944

Property and equipment, net 612,296 674,024

Other assets:
Right-of-use asset - operating lease 731,419 386,587
Investment 171,210 175,425
Goodwill 531,412 -
Intangible assets, net 303,556 -
Other assets 86,748 79,822
Total other assets 1,824,345 641,834

Total assets $ 12,390,607 $ 13,742,802

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 456,470 $ 342,790
Current portion of long-term loan payable 7,890 43,618
Current portion of lease liability - operating lease 180,939 150,931
Current portion of lease liability - finance lease 30,610 27,833
Accrued expenses 492,409 274,009
Deferred income 338,317 175,822
Other current liabilities 23,353 138,631

Total current liabilities 1,529,988 1,153,634

Non-current liabilities:
Lease liability - operating lease, net of current portion 565,825 247,656
Lease liability - finance lease, net of current portion 29,696 50,567
Loan payable - long term, net of current portion 6,753 12,696
Other noncurrent liabilities 80,817 65,802
Total non-current liabilities 683,091 376,721

Total liabilities $ 2,213,079 $ 1,530,355

Stockholders’ equity:
Common stock; 100,000,000 shares authorized, $0.00001 par value; 19,468,017 and 17,820,390 shares issued and outstanding as of June 30, 2022, and September 30, 2021, respectively $ 194 $ 178
Additional paid in capital 71,485,715 64,839,254
Accumulated deficit (61,486,600 ) (52,824,808 )
Accumulated other comprehensive income 178,219 197,823
Total stockholders’ equity 10,177,528 12,212,447

Total liabilities and stockholders’ equity $ 12,390,607 $ 13,742,802

Three Months Ended
March 31, 2022

Three Months Ended
March 31, 2021

Six Months Ended
March 31, 2022

Six Months Ended
March 31, 2021

Revenues, net $ 715,073 $ 414,064 $ 1,734,326 $ 932,051
Cost of sales 714,092 423,113 1,717,974 939,397
Gross profit 981 (9,049 ) 16,352 (7,346 )

Operating expenses 3,196,479 6,077,548 6,007,668 11,937,411
Loss from operations (3,195,498 ) (6,086,597 ) (5,991,316 ) (11,944,757 )

Loss from investment in unconsolidated affiliate (1,139 ) (1,919 ) (2,296 ) (3,975 )
Other income 42,461 41,093 85,218 53,714
Other expense (67,106 ) (34,455 ) (114,528 ) (78,987 )
Interest expense, net (2,415 ) (3,730 ) (4,978 ) (7,675 )
Net loss $ (3,223,697 ) $ (6,085,608 ) $ (6,027,900 ) $ (11,981,680 )
Basic and diluted loss per common share $ (0.18 ) $ (0.40 ) $ (0.33 ) $ (0.80 )

Basic and diluted weighted average number of common stock outstanding 18,300,531 15,260,986 18,154,879 14,998,201
The accompanying notes are an integral part of these unaudited consolidated financial statements.

5

NuZee, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

Three Months Ended
June 30, 2022

Three Months Ended
June 30, 2021

Nine Months Ended
June 30, 2022

Nine Months Ended
June 30, 2021

Three Months Ended
June 30, 2022

Three Months Ended
June 30, 2021

Nine Months Ended
June 30, 2022

Nine Months Ended
June 30, 2021

Revenues, net $ 774,019 $ 510,032 $ 2,508,345 $ 1,442,083
Cost of sales 857,672 413,446 2,575,646 1,352,843
Gross profit (loss) (83,653 ) 96,586 (67,301 ) 89,240

Operating expenses 2,546,608 3,165,840 8,554,276 15,103,252
Loss from operations (2,630,261 ) (3,069,254 ) (8,621,577 ) (15,014,012 )

Loss from equity method investment (1,919 ) (102 ) (4,215 ) (4,077 )
Other income 60,672 47,909 145,890 101,623
Other expense (60,361 ) (41,992 ) (174,889 ) (120,978 )
Interest expense, net (2,023 ) (3,603 ) (7,001 ) (11,278 )
Net loss $ (2,633,892 ) $ (3,067,042 ) $ (8,661,792 ) $ (15,048,722 )
Basic and diluted loss per common share $ (0.14 ) $ (0.17 ) $ (0.47 ) $ (0.94 )

Basic and diluted weighted average number of common stock outstanding 19,332,753 17,820,390 18,475,396 15,938,931
The accompanying notes are an integral part of these unaudited consolidated financial statements.
6
NuZee, Inc.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)

For the three months ended March 31 2022 2021
NuZee, Inc.
For the three months ended March 31 2022 2021
NuZee, Inc.
For the three months ended June 30 2022 2021
Net loss $ (3,223,697 ) $ (6,085,608 ) $ (2,633,892 ) $ (3,067,042 )

Foreign currency translation (7,095 ) 3,824 (45,197 ) (7,854 )
Total other comprehensive (loss) income, net of tax (7,095 ) 3,824
Total other comprehensive loss, net of tax (45,197 ) (7,854 )
Comprehensive loss $ (3,230,792 ) $ (6,081,784 ) $ (2,679,089 ) $ (3,074,896 )

For the six months ended March 31 2022 2021
NuZee, Inc.
For the six months ended March 31 2022 2021
Net loss $ (6,027,900 ) $ (11,981,680 )

Foreign currency translation 25,593 5,480
Total other comprehensive income, net of tax 25,593 5,480
Total other comprehensive (loss) income, net of tax 25,593 5,480
Comprehensive loss $ (6,002,307 ) $ (11,976,200 )

NuZee, Inc.
For the nine months ended June 30 2022 2021
Net loss $ (8,661,792 ) $ (15,048,722 )

Foreign currency translation (19,604 ) (2,374 )
Total other comprehensive loss, net of tax (19,604 ) (2,374 )
Total other comprehensive loss, net of tax (19,604 ) (2,374 )
Comprehensive loss $ (8,681,396 ) $ (15,051,096 )

The accompanying notes are an integral part of these unaudited consolidated financial statements.
7
NuZee, Inc.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(UNAUDITED)

Accumulated
Additional other
Common stock paid-in Accumulated comprehensive
Shares Amount capital deficit income Total

Balance September 30, 2021 17,820,390 $ 178 $ 64,839,254 $ (52,824,808 ) $ 197,823 $ 12,212,447

Exercise of warrants, net of issuance costs 384,447 4 1,721,014 - - 1,721,018
Stock option expense - - 1,124,187 - - 1,124,187
Other comprehensive gain - - - - 32,688 32,688
Net loss - - - (2,804,203 ) - (2,804,203 )
Balance December 31, 2021 18,204,837 $ 182 $ 67,684,455 $ (55,629,011 ) $ 230,511 $ 12,286,137

Warrant issuance costs - - (18,422 ) - - (18,422 )
Common stock issued for cash, ATM offering, net of issuance costs 42,448 - 88,426 - - 88,426
Common stock issued for Dripkit acquisition 178,681 2 386,842 - - 386,844
Stock option expense - - 935,447 - - 935,447
Exercise of stock options 14,000 - 12,600 - - 12,600
Restricted stock award issuance 117,920 1 9,589 - - 9,590
Other comprehensive loss - - - - (7,095 ) (7,095 )
Net loss - - - (3,223,697 ) - (3,223,697 )
Balance March 31, 2022 18,557,886 185 $ 69,098,937 $ (58,852,708 ) $ 223,416 $ 10,469,830
Common stock issued for cash, ATM offering, net of issuance costs 6,878 - $ 6,830 $ - $ - $ 6,830
Equity securities issued for cash, exempt offering, net of issuance costs 884,778 9 1,649,727 - - 1,649,736

Common stock issued to settle Dripkit Bulk Sales Holdback Amount 18,475 - 40,000 - - 40,000
Stock option expense - - 627,895 - - 627,895
Amortization of restricted stock award issued - - 62,326 - - 62,326
Other comprehensive loss - - - - (45,197 ) (45,197 )
Net loss - - - (2,633,892 ) - (2,633,892 )
Balance June 30, 2022 19,468,017 $ 194 $ 71,485,715 $ (61,486,600 ) $ 178,219 $ 10,177,528
8
Accumulated
Common stock Additional paid-in Accumulated other comprehensive
Shares Amount capital deficit income Total

Balance September 30, 2020 14,570,105 $ 146 $ 40,472,229 $ (34,272,778 ) $ 190,161 $ 6,389,758
Equity securities issued for cash, net of issuance costs 324,959 3 2,683,977 - - 2,683,980
Stock option expense - - 4,507,298 - - 4,507,298
Exercise of stock options 6,000 - 9,180 - - 9,180
Other comprehensive gain - - - - 1,656 1,656
Net loss - - - (5,896,072 ) - (5,896,072 )
Balance December 31, 2020 14,901,064 $ 149 $ 47,672,684 $ (40,168,850 ) $ 191,817 $ 7,695,800
-
Equity securities issued for cash, net of issuance costs 2,782,111 28 11,017,276 - - 11,017,304
Restricted stock award issuance 137,215 1 870,999 - - 871,000
Stock option expense - - 1,989,006 - - 1,989,006
Other comprehensive gain - - - - 3,824 3,824
Net loss - - - (6,085,608 ) (6,085,608 )
Balance March 31, 2021 17,820,390 178 $ 61,549,965 $ (46,254,458 ) $ 195,641 $ 15,491,326

Amortization of restricted stock award issued - - 91,036 - - 91,036
Stock option expense - - 1,506,613 - - 1,506,613
Other comprehensive loss - - - - (7,854 ) (7,854 )
Net loss - - - (3,067,042 ) - (3,067,042 )

Balance June 30, 2021 17,820,390 178 $ 63,147,614 $ (49,321,500 ) $ 187,787 $ 14,014,079
The accompanying notes are an integral part of these unaudited consolidated financial statements.

69
~~NuZee, Inc.~~
~~CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY~~
~~(UNAUDITED)~~

Accumulated
Additional other
Common stock paid-in Accumulated comprehensive
Shares Amount capital deficit income Total

Balance September 30, 2021 17,820,390 $ 178 $ 64,839,254 $ (52,824,808 ) $ 197,823 $ 12,212,447

Exercise of warrants 384,447 4 1,721,014 - - 1,721,018
Stock option expense - - 1,124,187 - - 1,124,187
Other comprehensive gain - - - - 32,688 32,688
Net loss - - - (2,804,203 ) - (2,804,203 )
Balance December 31, 2021 18,204,837 $ 182 $ 67,684,455 $ (55,629,011 ) $ 230,511 $ 12,286,137

Warrant issuance costs - - (18,422 ) - - (18,422 )
Common stock issued for cash, ATM offering 42,448 - 88,426 - - 88,426
Common stock issued for Dripkit acquisition 178,681 2 386,842 - - 386,844
Stock option expense - - 935,447 - - 935,447
Exercise of stock options 14,000 - 12,600 - - 12,600
Restricted stock award issuance 117,920 1 9,589 - - 9,590
Other comprehensive loss - - - - (7,095 ) (7,095 )
Net loss - - - (3,223,697 ) - (3,223,697 )
Balance March 31, 2022 18,557,886 185 $ 69,098,937 $ (58,852,708 ) $ 223,416 $ 10,469,830
Accumulated
Common stock Additional paid-in Accumulated other comprehensive
Shares Amount capital deficit income Total

Balance September 30, 2020 14,570,105 $ 146 $ 40,472,229 $ (34,272,778 ) $ 190,161 $ 6,389,758
Equity securities issued for cash 324,959 3 2,683,977 2,683,980
Stock option expense - - 4,507,298 - - 4,507,298
Exercise of stock options 6,000 - 9,180 - - 9,180
Other comprehensive gain - - - - 1,656 1,656
Net loss - - - (5,896,072 ) - (5,896,072 )
Balance December 31, 2020 14,901,064 $ 149 $ 47,672,684 $ (40,168,850 ) $ 191,817 $ 7,695,800
-
Equity securities issued for cash 2,782,111 28 11,017,276 - - 11,017,304
Restricted stock award issuance 137,215 1 870,999 871,000
Stock option expense - - 1,989,006 - - 1,989,006
Other comprehensive gain - - - - 3,824 3,824
Net loss - - - (6,085,608 ) (6,085,608 )
Balance March 31, 2021 17,820,390 178 $ 61,549,965 $ (46,254,458 ) $ 195,641 $ 15,491,326
~~The accompanying notes are an integral part of these unaudited consolidated financial statements.~~
7
NuZee, Inc.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

June 30, 2022 June 30, 2021
Six Months Ended Six Months Ended Nine Months Ended Nine Months Ended
March 31, 2022 March 31, 2021 June 30, 2022 June 30, 2021

Operating activities:
Net loss $ (6,027,900 ) $ (11,981,680 ) $ (8,661,792 ) $ (15,048,722 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization 166,161 161,911
Depreciation and amortization 295,178 254,929
Noncash lease expense 94,544 142,664 213,539 215,397
Stock option expense 2,059,634 6,496,304 2,687,529 8,002,917
Restricted stock award compensation 9,590 871,000
Restricted stock award issuance 71,916 962,036
Property and equipment impairment - 840,391 - 840,391
Sales allowance - (2,003 ) - (11,563 )
Loss on disposition of asset 12,618 - 12,618 -
Write-off of deferred offering costs - 477,605 - 477,605
Loss from investment in unconsolidated affiliate 2,296 3,975
Loss from equity method investment 4,215 4,077
Change in operating assets and liabilities:
Accounts receivable (91,648 ) (63,519 ) (18,752 ) (112,858 )
Inventories (48,156 ) 4,079 (99,452 ) (183,486 )
Prepaid expenses and other current assets (432,286 ) 50,448 (49,464 ) (141,018 )
Other assets (25,527 ) (1,367 ) (6,926 ) (1,362 )
Accounts payable 398,464 (7,529 ) 112,917 31,540
Deferred income 113,209 13,516 162,495 61,032
Lease liability – operating lease (91,525 ) (127,811 ) (210,194 ) (193,118 )
Accrued expenses and other current liabilities (305,129 ) 200,805 (206,140 ) (363,112 )
Other non-current liabilities 11,627 730 15,015 728
Net cash used in operating activities (4,154,028 ) (2,920,481 ) (5,677,298 ) (5,204,587 )

Investing activities:
Purchase of equipment (165,689 ) (122,554 ) (214,524 ) (141,445 )
Acquisition of Dripkit (373,832 ) - (413,069 ) -
Net cash used in investing activities (539,521 ) (122,554 ) (627,593 ) (141,445 )

Financing activities:
Proceeds from issuance of common stock, exercise of options 12,600 9,180 12,600 9,180
Repayment of loans (28,047 ) (25,971 ) (41,671 ) (40,407 )
Repayment of finance lease (11,870 ) (10,457 ) (18,094 ) (15,939 )
Stock issuance costs - (669,433 )
Proceeds from issuance of common stock, ATM offering 88,426 -
Proceeds from issuance of common stock, ATM offering, net of issuance costs 95,256 -
Proceeds from issuance of common stock, exercise of warrants, net of issuance costs 1,702,596 14,370,717 1,702,596 -
Advances received on sale of equity securities
300,000

-

Proceeds from issuance of equity securities, exempt offering, net of issuance costs 1,649,736 -
Proceeds from issuance of equity securities, net of issuance costs - 13,701,284
Cash paid for offering costs (368,783) -
Net cash provided by financing activities 2,063,705 13,674,036 3,031,640 13,654,118

Effect of foreign exchange on cash 25,593 5,480 (19,604 ) (2,374 )

Net change in cash (2,604,251 ) 10,636,481 (3,292,855 ) 8,305,712

Cash, beginning of period 10,815,954 4,398,545 10,815,954 4,398,545
Cash, end of period $ 8,211,703 $ 15,035,026 $ 7,523,099 $ 12,704,257

Supplemental disclosure of cash flow information:
Cash paid for interest $ 5,390 $ 7,792 $ 7,077 $ 11,278
Cash paid for taxes $ - $ 1,050 $ 800 $ 7,044

Non-cash transactions:
ROU assets and liabilities added during the period $ 558,371 $ - $ 558,371 $ -
Common stock issued in acquisition of Dripkit $ 386,844 $ - $ 426,844 $ -
Stock issuance costs accrued $ 97,867 $ - $ 273,762 $ -
The accompanying notes are an integral part of these unaudited consolidated financial statements.

810
NuZee, Inc.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

~~March 31,~~June 30, 2022

1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited interim consolidated financial statements of NuZee, Inc. (together with its subsidiaries, referred to herein as the “Company”, “we” or “NuZee”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), and rules of the Securities and Exchange Commission (the “SEC”), and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2021 as filed with the SEC on December 22, 2021. In the opinion of management, all adjustments, consisting of recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements as reported in the Annual Report on Form 10-K for the year ended September 30, 2021, have been omitted.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. We reclassified lease expenses associated with subleased property from ~~operating~~Operating expenses to ~~other~~Other expenses totaling $~~78,174~~ 118,885for the ~~six~~nine months ended ~~March 31,~~June 30, 2021 and $~~34,211~~ 40,712for the three months ended ~~March 31,~~June 30, 2021. We also reclassified $18,000of capitalized software costs included in Property and Equipment, net at September 30, 2021 to ~~Other~~Prepaid expenses and other current assets. These reclassifications had no effect on the previously reported net loss.

Principles of Consolidation

The Company prepares its financial statements on the accrual basis of accounting. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts, balances and transactions have been eliminated upon consolidation.

The Company has two wholly owned international subsidiaries in NuZee KOREA Ltd. (“NuZee KR”) and NuZee Investment Co., Ltd. (“NuZee INV”).
9

On February 25, 2022 (the “Closing Date”), the Company acquired substantially all the assets and certain specified liabilities (the “Acquisition”) of Dripkit, Inc., a Delaware corporation (“Dripkit”), pursuant to the Asset Purchase Agreement, dated as of February 21, 2022 (the “Asset Purchase Agreement”), by and among the Company, Dripkit, and Dripkit’s existing investors (the “Stock Recipients”) who executed joinders to the Asset Purchase Agreement as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the aggregate purchase price paid by the Company for the Acquisition was $860,000, plus the assumption of certain assumed liabilities, subject to certain adjustments and holdbacks as provided in the Asset Purchase Agreement. Dripkit is engaged in the business of manufacturing and sales of a single serve pour over coffee format that has a large-size single serve pour over pack that sits on top of the cup. Dripkit ~~will operate~~operates as a new Dripkit Coffee business division that is wholly owned by NuZee, Inc. The Company analyzed the Acquisition under ASC 805 and concluded that it should be accounted for as a business combination. The Acquisition has been included in the Company’s financial statements from the date of the Acquisition.
11

Earnings per Share

Basic earnings per common share is equal to net earnings or loss divided by the weighted average of shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options, warrants and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. As of ~~March 31,~~June 30, 2022, and ~~March 31,~~June 30, 2021, the total number of common stock equivalents was ~~8,741,993~~9,706,438 and ~~7,435,702~~8,289,864, respectively, comprised of stock options and warrants as of ~~March 31,~~June 30, 2022 and ~~March 31,~~June 30, 2021. The Company incurred a net loss for the three and ~~six~~nine months ended ~~March 31,~~June 30, 2022, and 2021, respectively, and therefore basic and diluted earnings per share for those periods are the same because all potential common equivalent shares would be antidilutive.

Capital Resources

Since its inception, the Company has devoted substantially all its efforts to business planning, research and development, recruiting management and technical staff, acquiring operating assets, raising capital, and the commercialization and manufacture of its single serve coffee products. The Company has generated limited revenues from its principal operations, and there is no assurance of future revenues.

As of ~~March 31,~~June 30, 2022, the Company had cash of $~~8,211,703~~7,523,099. However, the Company has not attained profitable operations since inception.

Major Customers

In the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021, revenue was primarily derived from major customers disclosed below.
SCHEDULE OF REVENUE BY MAJOR CUSTOMERS
~~Six~~Nine months ended ~~March 31,~~June 30, 2022:

Customer Name Sales Amount % of Total Revenue
Accounts Receivable
Amount
% of Total Accounts Receivable Sales Amount % of Total Revenue
Accounts Receivable
Amount
% of Total Accounts Receivable
Customer WP $ 520,208 30 % $ 190,978 30 % $ 660,997 26 % $ 239,579 42 %
Customer CU $ 252,137 15 % $ 189,768 29 % $ 252,137 10 % $ 52,564 9 %
Customer S $ 242,580 10 % $ 62,590 11 %

~~Six~~Nine months ended ~~March 31,~~June 30, 2021:

Customer Name Sales Amount % of Total Revenue
Accounts Receivable
Amount
% of Total Accounts Receivable Sales Amount % of Total Revenue
Accounts Receivable
Amount
% of Total Accounts Receivable
Customer WP $ 261,799 28 % $ 111,975 43 % $ 456,247 32 % $ 124,814 39 %
10
Lease

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the consolidated balance sheet and disclosing key information about leasing arrangements, specifically differentiating between different types of leases. The Company implemented ASU No. 2016-02 on October 1, 2019.

The Company performs a quarterly analysis of leases to determine if there are any operating leases that require recognition under ASC 842. The Company has a long-term operating lease for office and manufacturing space in Plano, Texas. The leased property in Plano, Texas, has a remaining lease term through June 2024. The lease has an option to extend beyond the stated termination date, but exercise of this option is not probable. The Company did not apply the recognition requirements of ASC 842 to operating leases with a remaining lease term of 12 months or less.

12
During our analysis of leases in the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we determined to renew the office and manufacturing space in Vista, California which was scheduled to expire on January 31, 2023, through March 31, 2025. The lease has a monthly base rent of $8,451, plus common area expenses. Along with the extension, we leased an additional 1,796square feet that ~~will have~~has a monthly base rent of $2,514through March 31, 2025. We extended our sub-leased property in Vista, California, through January 31, 2023. The lease has a monthly rent of $2,111 andhas been calculated as a ROU Asset co-terminus with the direct-leased property. The Seoul, Korea office and manufacturing space lease was extended through June 2022 and there is an apartment leased through June 2022. Additionally, the Company leased a new larger office and manufacturing space in Seoul, Korea beginning November 15, 2021, through November 15, 2023. The lease has a monthly expense of $7,040. Accordingly, we have added ROU assets and lease liabilities related to those leases at ~~March 31,~~June 30, 2022.

As of ~~March 31,~~June 30, 2022, our operating leases had a weighted average remaining lease term of ~~2.1~~1.6 years and a weighted-average discount rate of 55.5%%. Other information related to our operating leases is as follows:
SCHEDULE OF OTHER INFORMATION RELATED TO OPERATING LEASE

ROU Asset – October 1, 2021 $ 386,587 $ 386,587
ROU Asset added during the period 558,371 558,371
Amortization during the period (94,544 ) (213,539 )
ROU Asset –March 31, 2022 $ 850,414
ROU Asset – June 30, 2022 $ 731,419
Lease Liability – October 1, 2021 $ 398,587 $ 398,587
Lease Liability added during the period 558,371 558,371
Amortization during the period (91,525 ) (210,194 )
Lease Liability – March 31, 2022 $ 865,433
Lease Liability – June 30, 2022 $ 746,764

Lease Liability – Short-Term $ 349,825 $ 180,939
Lease Liability – Long-Term 515,608 565,825
Lease Liability – Total $ 865,433 $ 746,764

The table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining years to the lease liabilities recorded on the Consolidated Balance Sheet as of ~~March 31,~~June 30, 2022:

Amounts due within twelve months of ~~March 31,~~June 30,
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

2023 $ 373,017
2024 343,295
2025 187,692
Total Minimum Lease Payments 904,004
Less Effect of Discounting (38,571 )
Present Value of Future Minimum Lease Payments 865,433
Less Current Portion of Operating Lease Liabilities 349,825
Long-Term Operating Lease Liabilities $ 515,608
11

2023 $ 292,775
2024 322,280
2025 186,759
Total Minimum Lease Payments 801,814
Less Effect of Discounting (55,050 )
Present Value of Future Minimum Lease Payments 746,764
Less Current Portion of Operating Lease Liabilities 180,939
Long-Term Operating Lease Liabilities $ 565,825

On October 9, 2019, the Company entered into a lease agreement with Alliance Funding Group which provided for a sale lease back on certain packing equipment. The terms of this agreement require us to pay $2,987 per month through July 2024. As part of this agreement, Alliance Funding Group provided our equipment supplier with $124,500 for the purchase of this equipment. This transaction was accounted for as a ~~financing~~finance lease. As of ~~March 31,~~June 30, 2022, our ~~financing~~finance lease had a remaining lease term of ~~2.2~~1.9 years and a discount rate of ~~12.75~~12.75%%. The interest expense on finance lease liabilities for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 was $~~4,686~~6,741.

During the year ended September 30, 2021, we recorded an impairment to fully write off the related equipment as it was deemed no longer useful for our operations.

13
The table below summarizes future minimum finance lease payments at ~~March 31,~~June 30, 2022 for the twelve months ended ~~March 31:~~June 30:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS FOR FINANCE LEASES

2022 $ 33,113 $ 33,113
2023 33,113 33,113
2024 11,037 2,759
2025 -
2026 -
Total Minimum Lease Payments 77,263 68,985
Amount representing interest (10,733 ) (8,679 )
Present Value of Minimum Lease Payments 66,530 60,306
Current Portion of Finance Lease Obligations 29,665 30,610
Finance Lease Obligations, Less Current Portion $ 36,865 $ 29,696

Rent expense included in ~~general and administrative~~Operating expense for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021 was $~~123,373~~ 221,972and $~~89,876~~ 132,279, respectively. Rent expense included in ~~other~~Other expense for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021 was $~~99,209~~ 157,267and $~~78,174~~118,885, respectively.

Cash and non-cash activities associated with the leases for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 are as follows:
SCHEDULE OF CASH AND NON-CASH ACTIVITIES OF LEASES

Operating cash outflows from operating leases: $ 123,217 $ 216,334
Operating cash outflows from finance lease: $ 4,686 $ 6,741
Financing cash outflows from finance lease: $ 11,870 $ 18,094

In September 2020, we subleased the space at 1700 Capital Avenue in Plano, Texas, effective October 1, 2020, under terms that are co-terminus with the original lease ending June 30, 2024. During the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we recognized sublease income of $~~85,062~~140,753 pursuant to the sublease included in Other income on our financial statements. Future minimum lease payments to be received under that sublease as of ~~March 31,~~June 30, 2022, for each of the twelve months ended ~~March 31~~June 30 are as follows:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS OF SUBLEASE

2023 $ 125,104 $ 126,017
2024 128,881 129,835
2025 32,458
2026 -
2027 -
Total $ 286,443 $ 255,852

~~Advances Received on Sale of Equity Securities~~Loans
~~As of March 31, 2022, the Company recorded advances received from investors on sales of equity securities of $300,000~~ ~~as a current liability. See Note 8—Subsequent Events, Exempt Offering Pursuant to Regulation S—Sales of Equity Securities, to the Unaudited Consolidated Financial Statements.~~
12
~~Loans~~

On April 1, 2019, we purchased a delivery van from Ford Motor Credit for $41,627. The Company paid $3,500 as a down payment and financed $38,127 for 60 months at a rate of ~~2.9~~2.9%%. The loan is secured by the van. The outstanding balance on the loan at ~~March 31,~~June 30, 2022 and September 30, 2021 amounted to $~~16,581~~14,643 and $20,146, respectively.
The remaining loan payments are as follows:
SCHEDULE OF LOAN PAYMENTS

Ford Motor
Credit

2022 (Jul 2022 - Sep 2022) $ 1,951
2023 (Oct 2022 - Jun 2023) 5,939
Total Current Portion $ 7,890

2023 (Jul 2023 - Sep 2023) $ 6,753
Total Long-Term Portion $ 6,753

Grand Total $ 14,643

On February 15, 2019, NuZee KR entered into equipment financing for production equipment with Shin Han Bank for $60,563. In June 2019, NuZee KR purchased additional equipment and increased the loan with Shin Han Bank by $86,518. The financing ~~has~~had a term of 36 months at a rate of ~~4.33~~4.33%%. Principal payments began in July 2019. The outstanding balance on this loan at ~~March 31,~~June 30, 2022 and September 30, 2021 amounted to $~~11,686~~0 and $35,898, respectively. This loan was paid in full in this reporting period.

14
~~The remaining loan payments are as follows:~~
~~SCHEDULE OF LOAN PAYMENTS~~
Ford Motor Credit ShinHan Bank Total
2022 (Apr 2022 - Sep 2022) $ 3,888 4,619
2023 (Oct 2022 - Mar 2023) 3,945 7,067
Total Current Portion $ 7,833 11,686 19,519

2023 (Apr 2023 - Sep 2023) $ 8,748 -
Total Long-Term Portion $ 8,748 - 8,748
Grand Total $ 16,581 11,686 28,267

Revenue Recognition

In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (Topic 606) “Revenue from Contracts with Customers.” Topic 606 supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (Topic 605). The new standard’s core principle is that an entity will recognize revenue at an amount that reflects the consideration to which the entity expects to be entitled in exchange for transferring goods or services to a customer. The principles in the standard are applied in five steps: 1) Identify the contract(s) with a customer; 2) Identify the performance obligations in the contract; 3) Determine the transaction price; 4) Allocate the transaction price to the performance obligations in the contract; and 5) Recognize revenue when (or as) the entity satisfies a performance obligation. We adopted Topic 606 as of October 1, 2018, on a modified retrospective basis. The adoption of Topic 606 did not have a material impact on our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations.

Foreign Currency Translation

The financial position and results of operations of each of the Company’s foreign subsidiaries are measured using the foreign subsidiary’s local currency as the functional currency. Revenues and expenses of each such subsidiary have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities have been translated at the rates of exchange on the balance sheet date. The resulting translation gain and loss adjustments are recorded directly as a separate component of stockholders’ equity unless there is a sale or complete liquidation of the underlying foreign investment. Foreign currency translation adjustments recorded to other comprehensive ~~gain~~loss amounted to $$(~~25,593~~19,604) and $$(~~5,480~~2,374) for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021, respectively.

Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the results of operations as incurred.

Prepaid expenses and other current assets
Prepaid expenses and other current assets at June 30, 2022 and September 30, 2021, were as follows:
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

June 30,
2022

September 30,
2021

Prepaid expenses and other current assets $ 1,174,297 $ 482,288
The prepaid expenses and other current assets balance of $1,174,297 as of June 30, 2022 primarily consists of deferred financing costs related to our ATM offering of $368,783 and our underwritten public offering completed in August 2022 of $273,762 (see Note 8—Subsequent Events), prepaid insurance and deposits, and the balance of $482,288 as of September 30, 2021 primarily consists of prepaid insurance and a customer deposit.
Inventories

Inventory, consisting principally of raw materials, work in process and finished goods held for production and sale, is stated at the lower of cost or net realizable value, cost being determined using the weighted average cost method. The Company reviews inventory levels at least quarterly and records a valuation allowance when appropriate. At ~~March 31,~~June 30, 2022 and September 30, 2021, the carrying value of inventory was $~~631,284~~682,580 and $573,464, respectively.
13
SCHEDULE OF INVENTORY
March 31, 2022 September 30, 2021
June 30,
2022

September 30,
2021

Raw materials $ 573,733 $ 552,621 $ 638,444 $ 552,621
Finished goods 57,551 20,843 44,136 20,843
Less – Inventory reserve - - - -
Total $ 631,284 $ 573,464 $ 682,580 $ 573,464
15

Joint Venture

On January 9, 2020, a joint venture agreement was signed between Industrial Marino, S.A. de C.V. (5050%%) and the Company (5050%%) forming NuZee LATIN AMERICA (NLA), S.A. de C.V. NLA was formed pursuant to the laws of Mexico, with corporate domicile in Mazatlan, Mexico. As part of the capitalization of NLA, the Company contributed two co-packing machines to the joint venture. These machines had an aggregate carrying cost of $313,012. The Company received $110,000 in cash for this contribution and recorded an investment in NLA of $160,000 and a loss of $43,012 on the contribution of the machines to NLA.

The Company accounts for NLA using the equity method of accounting since the management of day-to-day operations at NLA ultimately lies with the Company’s joint venture partner as the operations of NLA are based in its partners facilities and our partner appoints the Chairman of the joint board of directors of NLA. As of ~~March 31,~~June 30, 2022, the only ~~activity~~activities in NLA ~~was~~were the contribution of two machines, as described above, and ~~other~~ start up ~~related~~and initial marketing and sales activities. $~~2,296~~4,215 and $~~3,975~~4,077 of ~~a loss was~~losses were recognized under the equity method of accounting during the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and ~~March 31,~~June 30, 2021, respectively.

2. GEOGRAPHIC CONCENTRATION

The Company is organized based on fundamentally one business segment although it does sell its products on a world-wide basis. The Company is organized in three geographical segments. The Company co-packs product for customers and produces and sells its products directly in North America and Korea. The Company has a minimally staffed office in Japan that provides support for import and export of product and materials between the U.S. and Japan, as well as investor relations support to our shareholders based in Japan. Information about the Company’s geographic operations for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021 are as follows:

Geographic Concentration
SCHEDULE OF GEOGRAPHIC OPERATIONS
Six Months
Ended Six Months
Ended
Nine Months
Ended

Nine Months
Ended

March 31, 2022 March 31, 2021 June 30, 2022 June 30, 2021
Net Revenue:
North America $ 1,401,285 $ 658,338 $ 2,031,781 $ 1,077,986
South Korea 333,041 273,713 476,564 364,097
Net Revenue $ 1,734,326 $ 932,051 $ 2,508,345 $ 1,442,083

Property and equipment, net: As of
March 31, 2022 As of
September 30, 2021 As of
June 30, 2022 As of
September 30, 2021
North America $ 411,733 $ 517,966 $ 400,842 $ 517,966
South Korea 257,969 154,562 209,254 154,562
Japan 2,943 1,496 2,200 1,496
Property and equipment, net $ 672,645 $ 674,024 $ 612,296 $ 674,024
3. RELATED PARTY TRANSACTIONS

For the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and ~~March 31,~~June 30, 2021, respectively, the Company had sales of $0 and $~~15,998~~28,299 of materials to NLA.

1416
4. BUSINESS COMBINATIONS
As described in Note 1, on February 25, 2022, the Company acquired substantially all the assets and certain specified liabilities of Dripkit pursuant to the Asset Purchase Agreement, dated as of February 21, 2022, by and among the Company, Dripkit, and Dripkit’s existing investors who executed joinders to the Asset Purchase Agreement as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the aggregate purchase price paid by the Company for the Acquisition was $860,000, plus the assumption of certain assumed liabilities, including a $13,000bridge loan and approximately $3,176of payables, subject to certain adjustments and holdbacks as provided in the Asset Purchase Agreement resulting in an acquisition accounting purchase price of $876,176. The Company analyzed the Acquisition under ASC 805 and concluded that it should be accounted for as a business combination.

Pursuant to the terms of the Asset Purchase Agreement, on the Closing Date,the cash portion of the purchase price was reduced by the following amounts: (a) $22,000, in satisfaction of a bridge loan made from the Company to Dripkit in February 2022 to provide Dripkit with operational financing prior to the Closing Date, (b) $35,500, as an indemnity holdback for the purpose of satisfying any indemnification claims made by the Company pursuant to the Asset Purchase Agreement, and (c) $40,000, as a cash bulk sales holdback (the “Cash Bulk Sales Holdback Amount”). In addition, on the Closing Date, the Company held back $40,000 worth of stock consideration as the Stock Bulk Sales Holdback Amount (together with the Cash Bulk Sales Holdback Amount, the “Bulk Sales Holdback Amount”). The Bulk Sales Holdback Amount was used to satisfy sales and use taxes owed by Dripkit to the State of New York as of the Closing Date, and amounts remaining after offsetting the cost of such sales and use taxes were distributed to Dripkit (in the case of the Cash Bulk Sales Holdback Amount) and delivered to the Stock Recipients (in the case of the Stock Bulk Sales Holdback Amount) in the third quarter of fiscal year 2022 pursuant to the terms of the Asset Purchase Agreement, as further described in Note 8-Subsequent Events.

On the Closing Date, after adjustments and holdbacks under the Asset Purchase Agreement, the Company paid the aggregate purchase price as follows: (i) cash paid by the Company to Dripkit was $257,000, and (ii) the Company issued to the Stock Recipients an aggregate of 178,681shares of the Company’s common stock. The Company repaid the entire outstanding principal amount of Dripkit’s Small Business Association Economic Injury Disaster Loan in the amount of $78,656. In addition, the Company recorded a liability on its balance sheet in Accounts Payable of $115,500related to potential future amounts due related to the Bulk Sales Holdback of $80,000and the indemnity holdback of $35,500.

~~The assets~~In the quarter ended June 30, 2022, pursuant to the terms of the Asset Purchase Agreement, the Bulk Sales Holdback Amount was used to satisfy sales and use taxes owed by Dripkit to the State of New York as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the amounts remaining after offsetting the cost of these sales and use taxes were distributed as follows in the quarter ended June 30, 2022: (i) $39,237 was distributed to Dripkit on May 9, 2022, in connection with the Cash Bulk Sales Holdback Amount, and (ii) 18,475 shares of common stock were issued to the Stock Recipients on April 25, 2022, in connection with the Stock Bulk Sales Holdback Amount.
Dripkit was acquired for purposes of supplementing our current product ~~offerings and~~offerings. Dripkit ~~will operate~~operates as a new Dripkit Coffee business division that is wholly-owned by NuZee, Inc.

The following table presents the allocation of the aggregate purchase price paid by the Company for the Acquisition of $860,000, plus the assumption of certain assumed liabilities, including a $13,000 bridge loan and approximately $3,176 of payables, resulting in an acquisition accounting purchase price of $876,176, to the assets acquired for the acquisition of Dripkit:
SCHEDULE OF ALLOCATION OF AGGREGATE PURCHASE PRICE
March 31, 2022
Total purchase price $ 876,176 $ 876,176
Assets acquired:
Inventory $ 9,664 $ 9,664
Property and equipment 5,100 5,100
Identifiable intangible assets 330,000 330,000
Total assets acquired $ 344,764 $ 344,764

Estimated fair value of net assets acquired $ 344,764 $ 344,764
Goodwill $ 531,412 $ 531,412

1517

Identified Intangibles and Goodwill

The Company identified tradename and customer relationships intangible assets. The tradename and customer relationships intangible assets will be amortized on a straight-line basis over their respective estimated useful lives. The goodwill recognized results from such factors as an assembled workforce and management’s industry know-how. See Note ~~5-Goodwill~~5—Goodwill and Intangible Assets for additional information on identified intangible assets and goodwill.

The ~~six~~nine months ended ~~March 31,~~June 30, 2022 includes the ~~operations~~operating results of Dripkit for the period from February 25, 2022, the date of acquisition, to ~~March 31,~~June 30, 2022. The consolidated statement of operations for the three and ~~six~~nine months ended ~~March 31,~~June 30, 2022 includes revenue of approximately $30,164 and $~~2,481~~32,645, respectively, net loss of approximately $109,249 and $122,370, respectively, and ~~a net loss of $13,121, including~~ amortization expense, of approximately $~~6,611~~19,833 ~~in both periods~~and $26,444, respectively, contributed by Dripkit.

InDuring the ~~six~~nine months ended ~~March 31,~~June 30, 2022, the Company incurred $~~261,561~~ 270,478of transaction costs related to the ~~Acquisition.~~Acquisition which are included in Operating expenses.

Unaudited Pro forma Financial Information
The following unaudited proforma financial information presents the combined results of operations of the Company and gives effect to the Dripkit Acquisition for the three and ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021, as if the Acquisition had occurred as of the beginning of the first period presented instead of on February 25, 2022.

The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the results of operations that would have been realized if the Acquisition had been completed on October 1, 2021, nor does it purport to project the results of operations of the combined company in future periods. The pro forma financial information does not give effect to any anticipated integration costs related to the acquired company.

The proforma financial information for the Company and Dripkit is as follows:
~~Three and six months ended March 31, 2022:~~
SCHEDULE OF UNAUDITED PRO FORMA FINANCIAL INFORMATION
Description 2022 2021 2022 2021

For the
three months ended
March 31,
For the
six months ended
March 31,
For the
three months ended
June 30,
For the
nine months ended
June 30,
Description 2022 2021 2022 2021 2022 2021 2022 2021
Revenues $ 772,165 $ 511,591 $ 1,811,693 $ 1,155,526 $ 774,019 $ 631,744 $ 2,585,802 $ 1,787,270
Net loss $ 3,025,896 $ 6,159,019 $ 5,866,279 $ 12,132,852 $ 2,624,975 $ 3,101,583 $ 8,491,254 $ 15,234,435

For purposes of the pro forma disclosures above, the primary adjustments for the three months and ~~six~~nine months ended ~~March 31,~~June 30, 2022 include the elimination of transaction costs of approximately $~~244,622~~8,917 and $~~261,561~~270,478, respectively.

5. GOODWILL AND INTANGIBLE ASSETS
Changes in goodwill for the ~~six~~nine months ended ~~March 31,~~June 30, 2022, consists of the following:
SCHEDULE OF CHANGES IN GOODWILL
March 31, 2022 June 30, 2022
Balance at September 30, 2021 $ - $ -
Dripkit acquisition 531,412 531,412
Balance at March 31, 2022 $ 531,412
Balance at June 30, 2022 $ 531,412

As of ~~March 31,~~June 30, 2022, the Company’s intangible assets consisted of the following:
SCHEDULE OF INTANGIBLE ASSETS
Amortization
Period
(Years) March 31, 2022 Amortization June 30, 2022
Gross Accumulated
Amortization Net
Period
(Years)
Gross Accumulated
Amortization Net
Tradenames 5 $ 230,000 $ 3,833 $ 226,167 5 $ 230,000 $ 15,333 $ 214,667
Customer relationships 3 100,000 2,778 97,222 3 100,000 11,111 88,889
Balance at March 31, 2022 $ 330,000 $ 6,611 $ 323,389
Balance at June 30, 2022 $ 330,000 $ 26,444 $ 303,556

Amortization expense was $~~6,611~~26,444 for the ~~six~~nine months ended ~~March 31,~~June 30, 2022.

1618
6. ISSUANCE OF EQUITY SECURITIES

Exercise of Warrants

In the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we issued 384,447 shares of common stock related to exercises of 2021 Warrants (as defined below), including 380,447 shares of common stock issued upon exercise of 380,447 Series A Warrants (as defined below) and 4,000 shares of common stock issued upon exercise of 8,000 Series B Warrants (as defined below). In connection with such exercises, in the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we received aggregate net proceeds of $1,702,596.

ATM Offering

On December 28, 2021, we entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Maxim Group LLC, as agent (the “Agent”), pursuant to which we ~~may~~could offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form ~~S-3 (the “ATM Offering”).~~S-3. Pursuant to the Equity Distribution Agreement, we ~~will pay~~paid the Agent a commission rate, in cash, equal to ~~3.0~~3.0%% of the aggregate gross proceeds from each sale of shares of our common stock under the Equity Distribution Agreement. The offer and sale of shares of our common stock ~~will be~~were made pursuant to a shelf registration statement on Form S-3 and the related prospectus (File No. 333-248531) initially filed by us with the SEC on September 1, 2020, and declared effective by the SEC on October 2, 2020, under the Securities Act. We ~~are~~were not obligated to make any sales of shares of our common stock under the Equity Distribution Agreement. In the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we issued and sold ~~42,448~~49,326 shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $~~88,426~~95,256. In connection with such sales, we paid compensation to the Agent in the amount of $~~2,735~~3,003. As further described in Note 8 – Subsequent Events, we terminated the Equity Distribution Agreement on August 5, 2022.

Grant of Restricted Stock Awards to the Company’s Independent Board Members
On March 17, 2022, pursuant to the Company’s non-employee director compensation policy, the Compensation Committee (the “Committee”) of the Company’s Board of Directors (the “Board”) granted 23,584restricted shares (the “Restricted Shares”) of the Company’s common stock to each of the Company’s five independent directors pursuant to the NuZee, Inc. 2013 Stock Incentive Plan, totaling 117,920Restricted Shares. The Restricted Shares are scheduled to vest in full on the one-year anniversary of the grant date, subject to each independent director’s continued service as a director of the Company. The Company recognized common stock compensation expense of $~~9,590~~ 71,916for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 related to these Restricted Shares.
April 2022 Exempt Offering
On April 13, 2022, pursuant to Securities Act registration exemptions under Regulation S and/or Section 4(a)(2) of the Securities Act, the Company sold 884,778 units (the “2022 Units”), at a price of $2.00 per 2022 Unit for aggregate net proceeds of $1,649,736, with each 2022 Unit consisting of (a) one share of our common stock and (b) one warrant (each, a “2022 Warrant” and collectively, the “2022 Warrants”) to purchase one whole share of our common stock with an initial exercise price of $2.00 per share.

7. STOCK OPTIONS AND WARRANTS

Options

During the ~~six~~nine months ended ~~March 31,~~June 30, 2022, the Company granted no100,000 new stock options, issued 14,000 shares upon the exercise of outstanding stock options, and had ~~203,166~~223,500 of stock options that were forfeited because of the termination of ~~employment, and issued~~ ~~14,000~~ ~~shares upon the exercise of outstanding stock options.~~employment.

1719
The fair value of each option award granted in the nine months ended June 30, 2022 was estimated on the date of grant using the Black-Scholes option valuation model using the assumptions noted as follows: expected volatility was based on the historical volatility of a peer group of companies. The expected term of options granted was determined using the simplified method under SAB 107 which represents the mid-point between the vesting term and the contractual term. The risk-free rate is calculated using the U.S. Treasury yield curve and is based on the expected term of the option.
The Black-Scholes option pricing model was used with the following weighted average assumptions for options granted during the nine months ended June 30, 2022:
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS FOR FAIR VALUE MEASUREMENT OF OPTIONS GRANTED
June 30, 2022
Risk-free interest rate 2.38 %
Expected option life 6 years
Expected volatility 70.53 %
Expected dividend yield 0.00 %
Exercise price $ 2.16

The following table summarizes stock option activity for ~~six~~the nine months ended ~~March 31,~~June 30, 2022:
SUMMARY OF STOCK OPTION ACTIVITY
Number of Shares Weighted Average
Exercise Price Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value Number of Shares
Weighted Average
Exercise
Price
Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value
Outstanding at September 30, 2021 4,511,691 $ 4.73 8.4 $ 452,206 4,511,691 $ 4.73 8.4 $ 452,206
Granted - - 100,000 2.16
Exercised (14,000 ) 0.90 (14,000 ) 0.90
Expired - - - -
Forfeited (203,166 ) 13.75 (223,500 ) 13.16
Outstanding at March 31, 2022 4,294,525 $ 4.32 8.0 $ 397,300
Exercisable at March 31, 2022 1,809,800 $ 4.91 7.0 $ 321,900
Outstanding at June 30, 2022 4,374,191 $ 4.25 7.8 $ -
Exercisable at June 30, 2022 1,932,379 $ 4.92 6.8 $ -

The Company is expensing these stock option awards on a straight-line basis over the requisite service period. The Company recognized stock option expense of $~~2,059,634~~2,687,529 and $8,002,917 for the ~~six~~nine months ended ~~March 31, 2022.~~June 30, 2022 and June 30, 2021, respectively. Unamortized option expense as of ~~March 31,~~June 30, 2022, for all options outstanding amounted to $~~2,667,796~~1,808,520. These costs are expected to be recognized over a weighted average period of ~~1.2~~1.4 years. ~~The Company recognized stock option expense of $6,496,304~~ ~~for the six months ended March 31, 2021.~~

A summary of the status of the Company’s nonvested options as of ~~March 31,~~June 30, 2022, is presented below:
SUMMARY OF UNVESTED SHARES
Nonvested options

Number of
Nonvested Options Weighted Average
Grant Date Fair Value Number of
Nonvested Options Weighted Average
Grant Date Fair Value
Nonvested options at September 30, 2021 2,870,799 $ 5.02 2,870,799 $ 5.02
Granted - - 100,000 2.16
Forfeited (36,500 ) 3.89 (54,333 ) 4.43
Vested (349,574 ) 5.95 (474,653 ) 5.90
Nonvested options at March 31, 2022 2,484,725 $ 4.90
Nonvested options at June 30, 2022 2,441,813 $ 4.74
Warrants

On June 23, 2020, as part of our agreement with Benchmark Company, LLC, the underwriter of the Company’s June 2020 registered public offering of common stock, we issued 40,250 warrants (the “2020 Warrants”) to purchase our common stock at an exercise price of $9.00 a share. ~~These warrants~~The 2020 Warrants became exercisable on December 23, 2020 and expire on June 18, ~~2025~~.2025.

On March 19, 2021, we entered into an underwriting agreement in connection with our registered public offering ~~(the “Offering”)~~ of (i) 2,777,777 units (the “2021 Units”), at a price to the public of $4.50 per 2021 Unit, with each 2021 Unit consisting of (a) one share of our common stock, (b) one Series A Warrant, and (c) one Series B Warrant (together with the Series A Warrants, the “2021 Warrants”), and (ii) 416,666 Series A Warrants and 416,666 Series B Warrants, each pursuant to the underwriter’s full exercise of their overallotment option with respect to such ~~warrants~~warrants..

20
Each Series A Warrant entitles the registered holder to purchase one share of our common stock at an exercise price of $4.50 per share. Each Series B Warrant entitles the registered holder thereof to purchase one-half of a share of our common stock at an exercise price of $5.85 per whole share. The 2021 Warrants have a term of 5 years.

The Series A and Series B Warrant holders are obligated to pay the exercise price in cash upon exercise of the 2021 Warrants unless we fail to maintain a current prospectus relating to the common stock issuable upon the exercise of the 2021 Warrants (in which case, the 2021 Warrants may only be exercised via a “cashless” exercise provision).

18
On April 13, 2022, pursuant to Securities Act registration exemptions under Regulation S and/or Section 4(a)(2) of the Securities Act, the Company sold 884,778 2022 Units, with each 2022 Unit consisting of (a) one share of our common stock and (b) one 2022 Warrant. Each 2022 Warrant entitles the holder to purchase one share of our common stock at an exercise price of $2.00 per share. The 2022 Warrants have a term of 5 years. Holders may exercise their 2022 Warrants on a “cashless” basis pursuant to a formula set forth in the form of 2022 Warrant.

The following table summarizes warrant activity for the ~~six~~nine months ended ~~March 31,~~June 30, 2022:
SCHEDULE OF WARRANT ACTIVITY
Number of Shares Issuable Upon Exercise of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value Number of Shares Issuable Upon Exercise of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value
Outstanding at September 30, 2021 4,831,915 $ 4.98 4.5 $ - 4,831,915 $ 4.98 4.5 $ -
Issued - - 884,778 2.00
Exercised (384,447 ) 4.51 (384,447 ) 4.51
Expired - - - -
Outstanding at March 31, 2022 4,447,468 $ 5.02 4.0 -
Exercisable at March 31, 2022 4,447,468 $ 5.02 4.0 $ -
Outstanding at June 30, 2022 5,332,246 $ 4.52 3.9 -
Exercisable at June 30, 2022 5,332,246 $ 4.52 3.9 $ -

In the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we issued 384,447 shares of common stock related to exercises of 2021 Warrants, including 380,447 shares of common stock issued upon exercise of 380,447 Series A Warrants and 4,000 shares of common stock issued upon exercise of 8,000 Series B Warrants. In connection with such exercises, in the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we received aggregate net proceeds of $1,702,596.

8. SUBSEQUENT EVENTS

~~Exempt Offering Pursuant to Regulation S—Sales~~Termination of Equity ~~Securities~~
~~On April 13, 2022, pursuant to Securities Act registration exemptions under Regulation S and/or Section 4(a)(2) of the Securities Act, the Company sold~~ ~~884,778~~ ~~units (the “2022 Units”), at a price of $2.00~~ ~~per 2022 Unit and an aggregate purchase price of approximately $1.77~~ ~~million, with~~ each 2022 Unit consisting of (a) one share of our common stock and (b) one warrant (the “2022 Warrants”) to purchase one whole share of our common stock with an initial exercise price of $2.00 per share~~. The 2022 Warrants have a term of~~ 5 ~~years.~~
~~Dripkit Acquisition—~~Distribution ~~of Bulk Sales Holdback Amount Pursuant to Asset Purchase~~ Agreement

On ~~May 2,~~August 5, 2022, ~~pursuant to the terms of the Asset Purchase~~we terminated our Equity Distribution Agreement the Bulk Sales Holdback Amount was used to satisfy sales and use taxes owed by Dripkit to the State of New York as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the amounts remaining after offsetting the cost of these sales and use taxes were distributed as follows: (i) $~~39,237~~ ~~was distributed to Dripkit on May 9, 2022, in connection~~ with the ~~Cash Bulk Sales Holdback Amount, and (ii)~~ ~~18,475~~ ~~shares of common stock were issued to the Stock Recipients on April 25, 2022, in connection with the Stock Bulk Sales Holdback Amount.~~Agent. See Note ~~4—Business Combinations~~6—Issuance of Equity Securities for additional information regarding the ~~Bulk Sales Holdback Amount~~Equity Distribution Agreement. Prior to termination, we issued and sold 49,326 shares of our common stock under the ~~Asset Purchase Agreement.~~Equity Distribution Agreement, raising net proceeds of $95,256.
~~Issuance of Options to New Employee~~August 2022 Underwritten Public Offering

On ~~April 1,~~August 10, 2022, ~~the Company issued a total~~we completed an underwritten public offering (the “Offering”) of ~~100,000~~4,200,000 ~~nonqualified~~shares of our common stock, ~~options~~pursuant to an Underwriting Agreement dated as of August 7, 2022 and a ~~new employee, including~~ ~~60,000~~ ~~performance-based options, which represents the maximum number of performance-based options that may be earned if all performance milestones are achieved for the applicable performance periods, and~~ ~~40,000~~ ~~time-based options. These options shall vest and become exercisable either (i) in the case of time-based options, as~~prospectus supplement to ~~1/3 on each anniversary of the grant date, or (ii) in the case of performance-based options, based on~~ the Company’s ~~Dripkit Coffee business division’s achievement~~effective shelf registration statement on Form S-3 (Registration No. 333-248531). The aggregate gross proceeds from the Offering were approximately $3.4 million. We received proceeds of ~~certain performance milestones established~~approximately $3.2 million, after deducting underwriting discounts and before deducting Offering costs payable by ~~the Compensation Committee for each fiscal year in the fiscal years ending September 30, 2022, 2023, and 2024.~~us.
1921

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

We are a specialty coffee company and, we believe, a leading co-packer of single serve pour over coffee in the United States, as well as a preeminent co-packer of coffee brew bags, which is also referred to as tea-bag style coffee. In addition to our portfolio of innovative single serve pour over and ~~tea-bag style~~coffee brew bag coffee products, we have recently expanded our product portfolio to offer a third type of single serve coffee format, DRIPKIT pour over products, as a result of our acquisition of substantially all of the assets of Dripkit, Inc.~~, a Delaware corporation~~ (“Dripkit”), in February 2022, as further described below. Our new, premium DRIPKIT pour over format features a large-size single serve pour over pack that sits on top of the cup and delivers ~~what we believe to be~~in our view a barista-quality coffee experience to coffee drinkers in the United States. Our mission is to leverage our position as a co-packer at the forefront of the North American single serve coffee market to revolutionize the way single serve coffee is enjoyed in the United States. While the United States is our core market, we also have manufacturing and sales operations in Korea and a joint venture in Latin America.

We believe we are the only commercial-scale producer that has the dual capacity to pack both single serve pour over coffee and ~~tea-bag style~~coffee brew bag coffee within the North American market. We intend to leverage our position to bebecome the commercial coffee manufacturer of choice and aim to become the preeminent leader for ~~major~~coffee companies seeking to enter into and grow within the single serve coffee market in North America. We ~~target existing high-margin companies and~~ are paid per-package based on the number of single serve coffee products produced by us. Accordingly, we consider our business model to be a form of tolling arrangement, as we receive a fee for almost every single serve coffee product our co-packing customers sell in the North American and Korean markets. While we financially benefit from the success of our co-packing customers through the sales of their respective single serve coffee products, we believe we are also able to avoid the risks associated with owning and managing the product and its related inventory.

We have also developed and sell NuZee branded single serve coffee products, including our flagship Coffee Blenders line of both single serve pour over coffee and coffee brew bag, or tea-bag style, coffee, which we believe offers consumers some of the best coffee available in a single serve application in the world. We offer DRIPKIT pour over packs direct to consumers through our website, wholesale business-to-business to hospitality customers, and co-pack for coffee roasters.

We may also consider co-packaging other products that are complementary to our current product offerings and provide us with a deeper access to our customers. In addition, we are continually exploring potential strategic partnerships, co-ventures, and mergers, acquisitions, or other transactions with existing and future business partners to generate additional business, drive growth, reduce manufacturing costs, expand our product portfolio, enter into new markets, and further penetrate the markets in which we currently operate. Our goal is to continue to expand our product portfolio to raise our visibility, consumer awareness and brand profile.

Since 2016, we have been primarily focused on single serve pour over coffee production. Over this time, we have developed expertise in the operation of our sophisticated packing equipment and the related production of our single serve pour over coffee products at ~~both our Vista, California facility and at our production operations in Seoul, Korea. In addition,~~ our manufacturing ~~facility and corporate headquarters in Plano, Texas is also operational.~~facilities. We have also expanded our co-packing expertise to ~~tea~~coffee brew bag ~~style~~ coffee products, which we believe are gaining traction in the United ~~States.~~States, as well as our DRIPKIT pour over products, which is our innovative new product offering that we believe has significant growth potential.
Operational Capacity and Recent Developments
We currently lease manufacturing facilities in Vista, California and Seoul, Korea to produce our single serve pour over or coffee brew bag coffee products. In November 2021, we entered into a new lease in Seoul, Korea for a larger office and manufacturing space. In addition, we have recently expanded our office and manufacturing space in Vista, California by approximately 2,000 square feet and also extended our current lease through March 2025 and our sub-leased property through January 2023.
As a result of our capital investments since 2015, including our acquisition of packing equipment from manufacturers whom we believe are the global leaders for supplying such machines, we presently have the annual capacity to produce up to 150 million single serve coffee products (pour over or coffee brew bags) at our two manufacturing facilities, which we believe is sufficient to meet our current and anticipated manufacturing requirements. In addition, in May 2022 we announced a new partnership pursuant to which a manufacturing partner in Knoxville, Tennessee has agreed to provide us with additional manufacturing, coffee roasting and co-packing capabilities, and facilitate distribution efforts to the Eastern United States. In connection with the foregoing operational developments and following our strategic analysis of our current and anticipated facility requirements, we have determined to transition our manufacturing operations away from the facility we previously operated in Plano, Texas. However, we intend to retain our executive office and administrative operations in Plano, Texas.
22
Dripkit Transaction
On February 25, 2022 (the “Closing Date”), the Company acquired substantially all of the assets and certain specified liabilities of Dripkit (the “Acquisition”) pursuant to the Asset Purchase Agreement, dated as of February 21, 2022 (the “Asset Purchase Agreement”), by and among the Company, Dripkit, and Dripkit’s existing investors (the “Stock Recipients”) who executed joinders to the Asset Purchase Agreement as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the aggregate purchase price paid by the Company for the Acquisition was $860,000, plus the assumption of certain assumed liabilities, subject to certain adjustments and holdbacks as provided in the Asset Purchase Agreement.

On the Closing Date, after adjustments and holdbacks under the Asset Purchase Agreement, the Company paid the aggregate purchase price as follows: (i) cash paid by the Company to Dripkit was $257,000, and (ii) the Company issued to the Stock Recipients an aggregate of 178,681 shares of the Company’s common stock. In addition, the Company repaid the entire outstanding principal amount of Dripkit’s Small Business Association Economic Injury Disaster Loan in the amount of $78,656.

20
On May 2, 2022, pursuant to the terms of the Asset Purchase Agreement, the Bulk Sales Holdback Amount was used to satisfy sales and use taxes owed by Dripkit to the State of New York as of the Closing Date. Pursuant to the terms of the Asset Purchase Agreement, the amounts remaining after offsetting the cost of these sales and use taxes were distributed as follows: (i) $39,237 was distributed to Dripkit on May 9, 2022, in connection with the Cash Bulk Sales Holdback Amount, and (ii) 18,475 shares of common stock were issued to the Stock Recipients on April 25, 2022, in connection with the Stock Bulk Sales Holdback Amount.

For additional information regarding the Acquisition and the Asset Purchase Agreement, see Note 4—Business Combinations to the Unaudited Consolidated Financial Statements.

Dripkit ~~will operate~~operates as a new Dripkit Coffee business division that is wholly owned by NuZee, Inc. On the Closing Date, the Company entered into an employment agreement for a term of two years with Ilana Kruger, the holder of approximately 71% of the capital stock of Dripkit, pursuant to which Ms. Kruger will serve as Chief Executive Officer of the new Dripkit Coffee business division.

Impact of the COVID-19 Pandemic

The ongoing COVID-19 global and national health emergency has caused significant disruption in the international and United States economies and financial markets. In the ~~six~~nine months ended ~~March 31,~~June 30, 2022, as a result of the COVID-19 pandemic and responses to the outbreak, certain of our customers slowed or delayed purchases of our co-packing services or single serve coffee products, and we also believe that potential sales of our single serve coffee products to new or potential customers in the hospitality industry were adversely impacted. We have also experienced delays in the submission and approval of custom artwork and packaging as well as the shipment to us of coffee for co-packing. In addition, we incurred lost production time due to employee absences. We do not believe, however, that these delays and disruptions had a significant effect on our business or results of operations to date, and in some cases, we have been able to mitigate these adverse effects in part by sourcing coffee and other supplies from alternative suppliers in the United States. The COVID-19 crisis may have an adverse impact on our business and financial results going forward that we are not currently able to fully determine or quantify. The COVID-19 crisis may adversely affect the ability of our customers to pay for goods delivered on a timely basis, or at all. Any increase in the amount or deterioration in the collectability of accounts receivable will adversely affect our cash flows and results of operations, requiring an increased level of working capital.

23
Geographic Concentration

Our operations are primarily split between two geographic areas: North America and Asia.

For the three months ended ~~March 31,~~June 30, 2022, net revenues attributable to our operations in North America totaled ~~$583,944~~$630,496 compared to ~~$251,850~~$419,648 of net revenues attributable to our operations in North America for the three months ended ~~March 31,~~June 30, 2021. For the ~~six~~nine months ended ~~March 31,~~June 30, 2022, net revenues attributable to our operations in North America totaled ~~$1,401,285~~$2,031,781 compared to ~~$658,338~~$1,077,986 of net revenues attributable to our operations in North America for the ~~six~~nine months ended ~~March 31,~~June 30, 2021. Additionally, as of ~~March 31,~~June 30, 2022, ~~$411,733~~$400,842 of our property and equipment, net was attributable to our North American operations, compared to $517,966 attributable to our North American operations as of September 30, 2021.

For the three months ended ~~March 31,~~June 30, 2022, net revenues attributable to our operations in Asia totaled ~~$131,129~~$143,523 compared to ~~$162,214~~$90,383 of net revenues attributable to our operations in Asia during the three months ended ~~March 31,~~June 30, 2021. For the ~~six~~nine months ended ~~March 31,~~June 30, 2022, net revenues attributable to our operations in Asia totaled ~~$333,041~~$476,564 compared to ~~$273,714~~$364,097 of net revenues attributable to our operations in Asia during the ~~six~~nine months ended ~~March 31,~~June 30, 2021. Additionally, as of ~~March 31,~~June 30, 2022, ~~$260,912~~$211,454 of our property and equipment, net was attributable to our Asian operations, compared to $156,058 attributable to our Asian operations as of September 30, 2021.

Results of Operations
Our results of operations for the three and ~~six~~nine months ended ~~March 31,~~June 30, 2022 includes the operations of Dripkit for the period from February 25, 2022, the date of the Acquisition, to ~~March 31,~~June 30, 2022. The Acquisition of Dripkit did not contribute to the periods prior to its acquisition in our financial statements, which therefore impacts comparisons to 2021 for our results of operations in the discussion that follows.

21
Comparison of three months ended ~~March 31,~~June 30, 2022 and 2021:

Revenue

Three months ended
March 31, Change
2022 2021 Dollars %
Revenue $ 715,073 $ 414,064 $ 301,009 73 %

Three months ended
June 30, Change
2022 2021 Dollars %
Revenue $ 774,019 $ 510,032 $ 263,987 52 %

For the three months ended ~~March 31,~~June 30, 2022, our revenue increased by ~~$301,009,~~$263,987, or approximately ~~73%~~52%, compared with the three months ended ~~March 31,~~June 30, 2021. This increase was primarily related to increased co-packing revenue to existing and new customers. In the third and fourth quarters of fiscal year 2021, we expanded our U.S. sales and support operations, which resulted in increased orders and increased co-packing opportunities in the three months ended ~~March 31,~~June 30, 2022.

Cost of sales and gross margin

Three months ended Three months ended

March 31, Change June 30, Change
2022 2021 Dollars % 2022 2021 Dollars %
Cost of sales $ 714,092 $ 423,113 $ 290,979 69 % $ 857,672 $ 413,446 $ 444,226 107 %
Gross profit (loss) 981 $ (9,049 ) $ 10,030 (111 )% (83,653 ) $ 96,586 $ (180,239 ) (187 )%
Gross profit (loss) % 0 % (2 )% (11 )% 19 %

For the three months ended ~~March 31,~~June 30, 2022, we generated a total gross ~~profit~~loss of ~~$981~~($83,653) from sales of our products and co-packing services, compared to a total gross ~~loss~~profit of ~~($9,049)~~$96,586 for the three months ended ~~March 31,~~June 30, 2021. The gross margin rate was 0%(11%) for the three months ended ~~March 31,~~June 30, 2022, and ~~(2)%~~19% for the three months ended ~~March 31,~~June 30, 2021. This ~~increase~~decrease in gross profit was driven primarily by ~~greater scale in our manufacturing operations due~~increased materials and labor costs as compared to ~~increased production during the current quarter versus~~ the same period in the prior ~~year, combined with increased sales offset by increased materials and labor costs.~~year.

24
Operating Expenses

Three months ended
March 31, Change
2022 2021 Dollars %
Operating Expenses $ 3,196,479 $ 6,077,548 $ (2,881,069 ) (47 )%
Three months ended

June 30, Change
2022 2021 Dollars %
Operating Expenses $ 2,546,608 $ 3,165,840 $ (619,232 ) (20 )%

For the three months ended ~~March 31,~~June 30, 2022, the Company’s operating expenses totaled ~~$3,196,479~~$2,546,608 compared to ~~$6,077,548~~$3,165,840 for the three months ended ~~March 31,~~June 30, 2021, representing a ~~47%~~20% decrease. This decrease is primarily attributable to a decrease in stock-based compensation expense, offset by an increase in operating expenses associated with greater staffing levels, marketing activities, and administrative costs. ~~Lease expenses associated with subleased property of $34,211 for the three months ended March 31, 2021 were reclassified from operating expenses to other expense.~~
Net Loss

Three months ended
March 31, Change
2022 2021 Dollars %
Net Loss $ 3,223,697 $ 6,085,608 $ (2,861,911 ) (47 )%
Three months ended

June 30, Change
2022 2021 Dollars %
Net Loss $ 2,633,892 $ 3,067,042 $ (433,150 ) (14 )%

For the three months ended ~~March 31,~~June 30, 2022, we generated a net loss of ~~$3,223,697~~$2,633,892 versus ~~$6,085,608~~$3,067,042 for the three months ended ~~March 31,~~June 30, 2021. This decrease in net loss is primarily attributable to lower stock-based compensation expense, offset by an increase in cost of sales, and an increase in operating expenses associated with greater staffing levels, marketing activities, and administrative costs.

22
Comparison of ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021:

Revenue

Six months ended
March 31, Change
2022 2021 Dollars %
Revenue $ 1,734,326 $ 932,051 $ 802,275 86 %
Nine months ended
June 30, Change
2022 2021 Dollars %
Revenue $ 2,508,345 $ 1,442,083 $ 1,066,262 74 %

For the ~~six~~nine months ended ~~March 31,~~June 30, 2022, our revenue increased by ~~$802,275,~~$1,066,262, or approximately ~~86%~~74% compared with the ~~six~~nine months ended ~~March 31,~~June 30, 2021. This increase was primarily related to increased co-packing revenue to existing and new customers. In the third and fourth quarters of fiscal year 2021, we expanded our U.S. sales and support operations, which resulted in increased orders and increased co-packing opportunities in the ~~six~~nine months ended ~~March 31,~~June 30, 2022.

Cost of sales and gross margin

Six months ended Nine months ended
March 31, Change June 30, Change
2022 2021 Dollars % 2022 2021 Dollars %
Cost of sales $ 1,717,974 $ 939,397 $ 778,577 83 % $ 2,575,646 $ 1,352,843 $ 1,222,803 90 %
Gross profit (loss) 16,352 $ (7,346 ) $ 23,698 (323 )% (67,301 ) $ 89,240 $ (156,541 ) (175 )%
Gross profit (loss)% 1 % (1 )% (3 )% 6 %

For the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we generated a total gross ~~profit~~loss of ~~$16,352,~~($67,301), from sales of our products and co-packing services, compared to a total gross ~~loss~~profit of ~~($7,346)~~$89,240 for the ~~six~~nine months ended ~~March 31,~~June 30, 2021. The gross margin rate was 1%(3%) for the ~~six~~nine months ended ~~March 31,~~June 30, 2022, and ~~(1)%~~6% for the ~~six~~nine months ended ~~March 31,~~June 30, 2021. This ~~increase~~decrease in gross profit was driven primarily by ~~greater scale in our manufacturing operations due~~increased materials and labor costs as compared to ~~increased production during the current six month period versus~~ the same period in the prior ~~year, combined with increased sales offset by increased materials and labor costs.~~year.

25
Operating Expenses

Six months ended
March 31, Change
2022 2021 Dollars %
Operating Expenses $ 6,007,668 $ 11,937,411 $ (5,929,743 ) (50 )%
Nine months ended
June 30, Change
2022 2021 Dollars %
Operating Expenses $ 8,554,276 $ 15,103,252 $ (6,548,976 ) (43 )%

For the ~~six~~nine months ended ~~March 31,~~June 30, 2022, the Company’s operating expenses totaled ~~$6,007,668~~$8,554,276 compared to ~~$11,937,411~~$15,103,252 for the ~~six~~nine months ended ~~March 31,~~June 30, 2021, representing a ~~50%~~43% decrease. This decrease is primarily attributable to a decrease in stock-based compensation expense ~~offset by an increase in operating expenses associated with greater staffing levels, marketing activities~~ and ~~administrative costs. Lease expenses associated with subleased property of $78,174 for the six months ended March 31, 2021 were reclassified from operating expenses to other expense.~~
~~Net Loss~~
Six months ended
March 31, Change
2022 2021 Dollars %
Net Loss $ 6,027,900 $ 11,981,680 $ (5,953,780 ) (50 )%
For the six months ended March 31, 2022, we generated a net loss of $6,027,900 versus $11,981,680 for the six months ended March 31, 2021. This decrease in net loss is primarily attributable to lower stock-based compensation expense,professional services costs, offset by an increase in operating expenses associated with greater staffing levels, marketing activities and administrative costs.
Net Loss
Nine months ended
June 30, Change
2022 2021 Dollars %
Net Loss $ 8,661,792 $ 15,048,722 $ (6,386,930 ) (42 )%
For the nine months ended June 30, 2022, we generated a net loss of $8,661,792 versus $15,048,722 for the nine months ended June 30, 2021. This decrease in net loss is primarily attributable to lower stock-based compensation expense, impairment charges and professional services costs, offset by an increase in operating expenses associated with greater staffing levels, marketing activities and administrative costs.

Liquidity and Capital Resources

Since our inception in 2011, we have incurred significant losses, and as of ~~March 31,~~June 30, 2022, we had an accumulated deficit of approximately ~~$58.9~~$61.5 million. We have not yet achieved profitability and anticipate that we will continue to incur significant sales and marketing expenses prior to recording sufficient revenue from our operations to offset these expenses. In the United States, we expect to incur additional losses because of the costs associated with operating as an exchange-listed public company. We are unable to predict the extent of any future losses or when we will become profitable, if at all.

23

To date, we have funded our operations primarily with proceeds from registered public offerings and private placements of shares of our common stock. Our principal use of cash is to fund our operations, which includes the commercialization of our single serve coffee products, the continuation of efforts to improve our products, administrative support of our operations and other working capital requirements.

As of ~~March 31,~~June 30, 2022, we had a cash balance of ~~$8,211,703.~~$7,523,099. We believe that our cash and cash equivalents will be sufficient to fund our planned operations and capital expenditure requirements for at least twelve months from ~~May 5,~~August 11, 2022. This evaluation is based on relevant conditions and events that are currently known or reasonably knowable. As a result, we could deplete our available capital resources sooner than we currently expect, and a reduction in consumer demand for, or revenues from the sale of, our single serve coffee products could further constrain our cash resources. We have based these estimates on assumptions that may prove to be wrong, and our operating projections, including our projected revenues from sales of our single serve coffee products, may change as a result of many factors currently unknown to us.

On December 28, 2021, we entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with Maxim Group LLC (“Maxim”), as agent (the “Agent”), pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3 (the “ATM Offering”). For additional information regarding the Equity Distribution Agreement, including the amount of net proceeds raised in the six months ended March 31, 2022, see “—~~Summary of Cash Flows—Financing Activities~~~~” and Note 6—Issuance of Equity Securities to the Unaudited Consolidated Financial Statements.~~
~~Subsequent to March 31, 2022, on~~ April 13, 2022, pursuant to Securities Act registration exemptions under Regulation S and/or Section 4(a)(2) of the Securities Act, we sold 884,778 units (the “2022 Units”), at a price of $2.00 per 2022 Unit ~~and an~~for aggregate ~~purchase price~~net proceeds of approximately ~~$1.77~~$1.65 million, with each 2022 Unit consisting of (a) one share of our common stock and (b) one warrant ~~(the~~(each, a “2022 Warrant” and collectively, the “2022 Warrants”) to purchase one whole share of our common stock with an initial exercise price of $2.00 per share. ~~Holders may exercise their 2022 Warrants on a “cashless” basis pursuant to a formula set forth in the form of 2022 Warrant.~~ For additional information regarding the 2022 Warrants, see Note ~~8—Subsequent Events~~7— Stock Options and Warrants to the Unaudited Consolidated Financial Statements.
26
On August 5, 2022, we terminated our Equity Distribution Agreement, dated December 28, 2021 (the “Equity Distribution Agreement”), with Maxim Group LLC, as agent (the “Agent”), pursuant to which we could from time to time offer and sell up to an aggregate of $20.0 million of shares of our common stock, subject to any applicable limits when using Form S-3, through the Agent in “at-the-market-offerings” (the “ATM Program”), as defined in Rule 415 under the Securities Act. Prior to termination, we issued and sold 49,326 shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $95,256. We terminated the Equity Distribution Agreement because we do not intend to raise additional capital through the ATM Program.
On August 10, 2022, we completed an underwritten public offering (the “Offering”) of 4,200,000 shares of our common stock, pursuant to an Underwriting Agreement dated as of August 7, 2022 and a prospectus supplement to the Company’s effective shelf registration statement on Form S-3 (Registration No. 333-248531). The aggregate gross proceeds from the Offering were approximately $3.4 million. We received proceeds of approximately $3.2 million, after deducting underwriting discounts and before deducting Offering costs payable by us.

In the future, we expect to seek to raise additional capital through public or private equity ~~offerings, such as through sales of our common stock under the Equity Distribution Agreement.~~offerings. We also may receive additional funds upon the exercise for cash of outstanding warrants, if and when exercised for cash at the election of the warrant holders, including the Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants” and, collectively with the Series A Warrants, the “2021 Warrants”) that were sold by us in March 2021 in an underwritten registered public ~~offering.~~offering and the 2022 Warrants. For additional information regarding the 2021 Warrants, see Note 7—Stock Options and Warrants to the Unaudited Consolidated Financial Statements.

In the long term, we expect we will need to raise additional funds to support our operating activities, and such funding may not be available to us on acceptable terms, or at all. The timing and amount of funds that we will need to raise will depend on a number of factors, including our ability to generate a sufficient amount of revenues from the sale of our single serve coffee products to fund our business operations and the timing and amount of funds received upon the exercise for cash of outstanding warrants by the warrant holders. If we are unable to raise additional funds when needed, our operations and ability to execute our business strategy could be adversely affected. Until we can generate a sufficient amount of revenue, we may seek to raise additional funds through equity, equity-linked or debt financings. If we raise additional funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to holders of our equity securities and could contain covenants that restrict our operations. Any additional equity financing may be dilutive to our stockholders.

Contractual Obligations

Our significant contractual cash requirements as of ~~March 31,~~June 30, 2022, primarily include payments for operating and finance lease liabilities and principal and interest on loans. Additionally, we may incur purchase obligations in the ordinary course of business that are enforceable and legally binding and enter into enforceable agreements to purchase goods or services that specify all significant terms, including fixed or minimum quantities to be purchased and fixed or estimated prices to be paid at the time of settlement. As of ~~March 31,~~June 30, 2022, we had payments for lease and loan obligations of approximately ~~$960,230,~~$821,713, of which ~~$399,009~~$219,439 are payable within 12 months as of ~~March 31,~~June 30, 2022. We had no purchase obligations as of ~~March 31, 2022~~June 30, 2022.

24
Summary of Cash Flows

Six Months
Ended Nine Months Ended
March 31, June 30,
2022 2021 2022 2021
Cash used in operating activities $ (4,154,028 ) $ (2,920,481 ) $ (5,677,298 ) $ (5,204,587 )
Cash used in investing activities $ (539,521 ) $ (122,554 ) $ (627,593 ) $ (141,445 )
Cash provided by financing activities $ 2,063,705 $ 13,674,036 $ 3,031,640 $ 13,654,118 )
Effect of foreign exchange on cash $ 25,593 $ 5,480 $ (19,604 ) $ (2,374 )
Net change in cash $ (2,604,251 ) $ 10,636,481 $ (3,292,855 ) $ 8,305,712

27
Operating Activities

We used ~~$4,154,028~~$5,677,298 and ~~$2,920,481~~$5,204,587 of cash in operating activities during the ~~six~~nine months ended ~~March 31,~~June 30, 2022, and 2021, respectively, principally to fund our operations.

Investing Activities

We used ~~$539,521~~$627,593 and ~~$122,554~~$141,445 of cash in investing activities during the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021, respectively. Cash used in the ~~six~~nine months ended ~~March 31,~~June 30, 2022 was for the acquisition of substantially all of the assets of Dripkit and the purchase of equipment. Cash used in the ~~six~~nine months ended ~~March 31,~~June 30, 2021 was for the purchase of equipment.

Financing Activities

Historically, we have funded our operations primarily through the issuance of our equity securities.

Cash provided by financing activities of ~~$2,063,705~~$3,031,640 and ~~$13,674,036~~$13,654,118 for the ~~six~~nine months ended ~~March 31,~~June 30, 2022 and 2021, respectively, is primarily related to proceeds received upon the exercise of outstanding 2021 Warrants by the 2021 Warrant holders, ~~advances received on~~as further described below, the sale of equity securities from our exempt offering in April 2022, and the issuance of shares of our common stock under the Equity Distribution Agreement in the ~~six~~nine months ended ~~March 31,~~June 30, 2022, ~~as further described below,~~ and issuance of equity securities in the ~~six~~nine months ended ~~March 31,~~June 30, 2021.
Exercise of Warrants

In the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we issued 384,447 shares of common stock related to exercises of 2021 Warrants, including 380,447 shares of common stock issued upon exercise of 380,447 Series A Warrants and 4,000 shares of common stock issued upon exercise of 8,000 Series B Warrants. In connection with such exercises, in the ~~six~~nine months ended ~~March 31,~~June 30, 2022, we received aggregate net proceeds of $1,702,596. For additional information regarding the Series A Warrants and Series B Warrants, see Note 7—Stock Options and Warrants to the Unaudited Consolidated Financial Statements.

~~ATM Offering~~
On December 28, 2021, we entered into the Equity Distribution Agreement with Maxim, as Agent, pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3. The offer and sale of shares will be made pursuant to a shelf registration statement on Form S-3 and the related prospectus (File No. 333-248531) initially filed by us with the SEC on September 1, 2020, and declared effective by the SEC on October 2, 2020, under the Securities Act. We are not obligated to make any sales of shares of our common stock under the Equity Distribution Agreement. In the six months ended March 31, 2022, we issued and sold 42,448 shares of our common stock under the Equity Distribution Agreement, raising net proceeds of $88,426.
25
Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements that have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. US GAAP provides the framework from which to make these estimates, assumption and disclosures. We choose accounting policies within US GAAP that management believes are appropriate to accurately and fairly report our operating results and financial position in a consistent manner. Management regularly assesses these policies in light of current and forecasted economic conditions. See Note 1—Basis of Presentation and Summary of Significant Accounting Policies of the Notes to the Unaudited Consolidated Financial Statements for a summary of our accounting policies.

Except as described below, there were no significant and material changes in our critical accounting policies and use of estimates during the three and ~~six~~nine months ended ~~March 31,~~June 30, 2022, as compared to those disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, filed with the SEC on December 22, 2021.

28
Business Combinations

On February 25, 2022, we completed the acquisition of substantially all of the assets of Dripkit. Accounting for business combinations requires us to make significant estimates and assumptions, especially at the acquisition date with respect to tangible and intangible assets acquired. We use our best estimates and assumptions to accurately assign fair value to the tangible and intangible assets acquired at the acquisition date as well as the useful lives of those acquired intangible assets. Examples of critical estimates in valuing certain of the intangible assets and goodwill acquired include but are not limited to future (i) expected cash flows from acquired customer relationships and trademarks, (ii) attrition, (iii) revenues, (iv) royalty rate, (v) operating profit and (vi) discount rate.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is collected and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer are responsible for establishing and maintaining disclosure controls and procedures for our Company. In designing and evaluating our disclosure controls and procedures, management recognizes that no matter how well conceived and operated, disclosure controls and procedures can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our “disclosure controls and procedures” (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control Over Financial Reporting

~~During the quarter ended March 31,~~On February 25, 2022, we completed the acquisition of substantially all of the assets of Dripkit. We are ~~currently~~ in the process of ~~evaluating the impact of this acquisition on our system of internal control over financial reporting. We are also developing plans to integrate~~integrating Dripkit’s processes and controls into our current state processes. Except for this ~~current evaluation~~integration of Dripkit into our overall internal control over financial reporting program, there were no changes in our internal control over financial reporting during the quarter ended ~~March 31,~~June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2629

PART II.

Item 1. Legal Proceedings

OnAs previously disclosed, on November 23, 2021, Next Vision, Inc. (the “Consultant”) filed a complaint against the Company in the Superior Court of California, County of San Diego Central Division (Case No. 37-2021-00049557-CU-BC-CTL) (the “Complaint”). The Complaint alleges that the Company’s delay in issuing shares of the Company’s common stock (the “Shares”) to the Consultant after receiving due notice from the Consultant of its intent to exercise vested stock options to acquire 70,000 Shares, as initially granted in 2018 (or, as adjusted to account for the Company’s reverse stock split effected on November 12, 2019, vested stock options to acquire 23,334 Shares) (the “Options”), which had previously been issued to the Consultant as compensation for consulting services provided in 2018, breached express and implied contractual obligations to the Consultant and resulted in the Company reporting an overstated amount of income on the IRS Form 1099-B that was issued to the Consultant for U.S. federal tax purposes. In addition, the Complaint alleges that the 23,334 Shares issued to the Consultant upon exercise of the Options improperly contained a six-month restriction on resale and that such restriction prevented the Consultant from selling the Shares at the desired time. The Complaint seeks equitable relief requiring the Company to issue an IRS Form 1099-NEC to reflect the correct amount of compensation. The Complaint also seeks compensatory damages, including to recover for alleged lost profits due to the alleged improper six-month restriction on resale for the Shares, as well as punitive damages, costs of suit, attorney’s fees, and interest. On
As previously disclosed, on January 20, 2022, the Company filed its general denial and answer in which it raised affirmative defenses and disputed the claims contained in the Complaint.
On July 1, 2022, the Court set a trial date for August 11, 2023 and ordered the Company and the Consultant to mediate prior to October 28, 2022.

We believe the allegations set forth in the Complaint are without merit and intend to defend vigorously against the allegations. However, the Company is not able to predict the outcome, and there is no assurance that the Company will be successful in its defense.

From time to time, we may be subject to other legal proceedings and claims in the ordinary course of business. The results of any future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

Item 1A. Risk Factors

~~Except as set forth below, there~~Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on December 22, 2021, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock. There have been no material changes to our risk factors from those disclosed in our Annual Report on Form 10-K filed with the SEC on December 22, 2021.
A significant portion of our total outstanding shares of common stock are eligible to be sold into the market in the near future, including pursuant to Rule 144, which could cause the market price of our common stock to drop significantly, even if our business is doing well.
Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. We have also registered all shares of common stock that are reserved for issuance under the NuZee, Inc. 2019 Stock Incentive Plan and all shares of common stock currently reserved for issuance under the NuZee, Inc. 2013 Stock Incentive Plan. As a result, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and the lock-up agreements described in our filings with the SEC. A sale under Rule 144 or under any other exemption from the Securities Act, if available, or pursuant to subsequent registrations of our shares of common stock, may have a depressive effect upon the price of our shares of common stock in any active market that may develop. We believe that a significant portion of our total outstanding shares of common stock may be sold in the public market without restriction by non-affiliates pursuant to Rule 144.
We have also entered into the Equity Distribution Agreement with Maxim, as Agent, pursuant to which we may offer and sell, from time to time, shares of our common stock through the Agent in “at-the-market-offerings”, as defined in Rule 415 under the Securities Act, having an aggregate offering price of up to $20,000,000, subject to any applicable limits when using Form S-3. Sales of a substantial number of shares of common stock under the Equity Distribution Agreement, or the perception that those sales may occur, could cause the market price of our common stock to decline.
27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In the quarter ended ~~March 31,~~June 30, 2022, we issued the following securities that were not registered under the Securities Act:

● ~~On February~~Pursuant to the terms of the Asset Purchase Agreement, 18,475 shares of common stock were issued to the Stock Recipients on April 25, 2022 in connection with the ~~completion of our acquisition of~~ ~~substantially all of~~Stock Bulk Sales Holdback Amount. See Note 4—Business Combinations for additional information regarding the ~~assets of Dripkit pursuant to~~Stock Bulk Sales Holdback Amount and the Asset Purchase ~~Agreement,~~ ~~we issued an aggregate of 178,681 shares of our common stock to the Stock Recipients~~Agreement. . For additional information, see Note 4—Business Combinations to the Unaudited Consolidated Financial Statements and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Dripkit Transaction” herein. Each Stock Recipient was an accredited investor (as that term is defined in Regulation D under the Securities Act).
● On February 8, 2022, we issued 14,000 shares of our common stock upon exercise of stock options previously issued to an advisor for certain legal services. In connection with such exercise, the Company received $12,600 in cash as payment of the aggregate exercise price.

In issuing shares of our common stock in the transactions described above, the Company relied on the exemptions from the registration requirements of the Securities Act provided for in Regulation D and/or Section 4(a)(2) of the Securities Act.
~~Item 5. Other Information~~
~~Information Required by Item 407(c)(3) of Regulation S-K~~

As previously disclosed, on March 17, 2022, the Company’s Board of Directors (the “Board”) approved and adopted the Third Amended and Restated Bylaws of the Company (the “New Bylaws”). The following briefly describes provisions in the New Bylaws that made changes to the Company’s procedures by which stockholders may recommend nominees to the Board and submit stockholder proposals at annual meetings of stockholders:
1. Section 1.10(a) of the New Bylaws permits stockholders to submit proposals (including director nominations) at any annual meeting of stockholders if advance notice thereof has been timely delivered to, or mailed and received by, the secretary of the Company not less than 90 nor more than 120 days prior to the anniversary date of the immediately preceding annual meeting of stockholders. However, if the annual meeting of stockholders is changed by more than 30 calendar days before or after such anniversary date, different timing provisions will apply as set forth in the New Bylaws.
2. Section 1.10(b) of the New Bylaws requires a stockholder’s notice of nomination of a person for election as a director to include, among other information, such stockholder’s name and address and the number and class of all shares beneficially owned by such stockholder, the name of the person to be nominated, the number and class of all shares of each class of stock of the Company beneficially owned by such person, and such person’s signed consent to serve as a director of the Company, if elected.
Pursuant to the New Bylaws, if a stockholder wishes to submit a proposal (including a director nomination) at the 2023 annual meeting of stockholders otherwise than for inclusion in next year’s proxy materials, a stockholder must do so not later than December 17, 2022, nor earlier than the close of business on November 17, 2022. However, if the date of our 2023 annual meeting of stockholders is not held between February 15, 2023 and April 16, 2023, to be timely, notice by the stockholder must be received not later than the 10th day following the day on which notice of the date of the 2023 annual meeting of stockholders was mailed or first publicly announced or disclosed, whichever occurs first.
2830

Item 6. Exhibits

EXHIBIT NO. DESCRIPTION
2.1+ Asset Purchase Agreement, dated as of February 21, 2022, by and among the Company, Dripkit, Inc., and Dripkit’s existing investors party thereto (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on February 22, 2022, SEC File Number 001-39338)
3.1 Articles of Incorporation of the Company, dated July 15, 2011 (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed on September 6, 2011, SEC File Number 333-176684)
3.2 Certificate of Amendment to Articles of Incorporation of the Company, dated May 6, 2013 (incorporated by reference to Exhibit 3.01(b) to the Company’s Current Report on Form 8-K filed on April 25, 2013, SEC File Number 333-176684)
3.3 Certificate of Amendment to Articles of Incorporation of the Company, dated October 28, 2019 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 28, 2019, SEC File Number 000-55157)
3.4 Third Amended and Restated Bylaws of the Company, effective March 17, 2022 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on March 23, 2022, SEC File Number 001-39338)
4.1 Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 15, 2022, SEC File Number 001-39338)
~~10.1†~~* ~~Description of Registrant’s Non-Employee Director Compensation Policy~~
31.1* Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2* Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1** Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2** Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS Inline XBRL Instance Document***
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

~~† Indicates management contract or compensatory plan.~~
* Filed herewith.

** Furnished herewith.

*** The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
+ Certain schedules to this agreement have been omitted pursuant to Item 601 of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the Securities and Exchange Commission upon request.
2931

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date: ~~May~~August 12, 2022 NUZEE, INC.

By: /s/ Masateru Higashida
Masateru Higashida, Chief Executive Officer and President (Principal Executive Officer), Secretary, Treasurer, and Director

By: /s/ Patrick Shearer
Patrick Shearer, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

3032

	March 31, 2022			September 30, 2021
ASSETS
Current assets:
Cash	$	8,211,703		$	10,815,954
Accounts receivable, net		646,886			555,238
Inventories, net		631,284			573,464
Prepaid expenses and other current assets		1,012,441			482,288
Total current assets		10,502,314			12,426,944

Property and equipment, net		672,645			674,024

Other assets:
Right-of-use asset - operating lease		850,414			386,587
Investment		173,129			175,425
Goodwill		531,412			-
Intangible assets, net		323,389			-
Other assets		105,349			79,822
Total other assets		1,983,693			641,834

Total assets	$	13,158,652		$	13,742,802

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	839,121		$	342,790
Current portion of long-term loan payable		19,519			43,618
Current portion of lease liability - operating lease		349,825			150,931
Current portion of lease liability - finance lease		29,665			27,833
Accrued expenses		177,089			274,009
Deferred income		289,031			175,822
Other current liabilities		45,922			138,631
Advances received on sale of equity securities		300,000			-
Total current liabilities		2,050,172			1,153,634

Non-current liabilities:
Lease liability - operating lease, net of current portion		515,608			247,656
Lease liability - finance lease, net of current portion		36,865			50,567
Loan payable - long term, net of current portion		8,748			12,696
Other noncurrent liabilities		77,429			65,802
Total non-current liabilities		638,650			376,721

Total liabilities	$	2,688,822		$	1,530,355

Stockholders’ equity:
Common stock; 100,000,000 shares authorized, $0.00001 par value; 18,557,886 and 17,820,390 shares issued and outstanding as of March 31, 2022, and September 30, 2021, respectively	$	185		$	178
Additional paid in capital		69,098,937			64,839,254
Accumulated deficit		(58,852,708	)		(52,824,808	)
Accumulated other comprehensive income		223,416			197,823
Total stockholders’ equity		10,469,830			12,212,447

Total liabilities and stockholders’ equity	$	13,158,652		$	13,742,802

	June 30, 2022			September 30, 2021
ASSETS
Current assets:
Cash	$	7,523,099		$	10,815,954
Accounts receivable, net		573,990			555,238
Inventories, net		682,580			573,464
Prepaid expenses and other current assets		1,174,297			482,288
Total current assets		9,953,966			12,426,944

Property and equipment, net		612,296			674,024

Other assets:
Right-of-use asset - operating lease		731,419			386,587
Investment		171,210			175,425
Goodwill		531,412			-
Intangible assets, net		303,556			-
Other assets		86,748			79,822
Total other assets		1,824,345			641,834

Total assets	$	12,390,607		$	13,742,802

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	456,470		$	342,790
Current portion of long-term loan payable		7,890			43,618
Current portion of lease liability - operating lease		180,939			150,931
Current portion of lease liability - finance lease		30,610			27,833
Accrued expenses		492,409			274,009
Deferred income		338,317			175,822
Other current liabilities		23,353			138,631

Total current liabilities		1,529,988			1,153,634

Non-current liabilities:
Lease liability - operating lease, net of current portion		565,825			247,656
Lease liability - finance lease, net of current portion		29,696			50,567
Loan payable - long term, net of current portion		6,753			12,696
Other noncurrent liabilities		80,817			65,802
Total non-current liabilities		683,091			376,721

Total liabilities	$	2,213,079		$	1,530,355

Stockholders’ equity:
Common stock; 100,000,000 shares authorized, $0.00001 par value; 19,468,017 and 17,820,390 shares issued and outstanding as of June 30, 2022, and September 30, 2021, respectively	$	194		$	178
Additional paid in capital		71,485,715			64,839,254
Accumulated deficit		(61,486,600	)		(52,824,808	)
Accumulated other comprehensive income		178,219			197,823
Total stockholders’ equity		10,177,528			12,212,447

Total liabilities and stockholders’ equity	$	12,390,607		$	13,742,802

	Three Months Ended March 31, 2022			Three Months Ended March 31, 2021			Six Months Ended March 31, 2022			Six Months Ended March 31, 2021
Revenues, net	$	715,073		$	414,064		$	1,734,326		$	932,051
Cost of sales		714,092			423,113			1,717,974			939,397
Gross profit		981			(9,049	)		16,352			(7,346	)

Operating expenses		3,196,479			6,077,548			6,007,668			11,937,411
Loss from operations		(3,195,498	)		(6,086,597	)		(5,991,316	)		(11,944,757	)

Loss from investment in unconsolidated affiliate		(1,139	)		(1,919	)		(2,296	)		(3,975	)
Other income		42,461			41,093			85,218			53,714
Other expense		(67,106	)		(34,455	)		(114,528	)		(78,987	)
Interest expense, net		(2,415	)		(3,730	)		(4,978	)		(7,675	)
Net loss	$	(3,223,697	)	$	(6,085,608	)	$	(6,027,900	)	$	(11,981,680	)
Basic and diluted loss per common share	$	(0.18	)	$	(0.40	)	$	(0.33	)	$	(0.80	)

Basic and diluted weighted average number of common stock outstanding		18,300,531			15,260,986			18,154,879			14,998,201

	Three Months Ended June 30, 2022			Three Months Ended June 30, 2021			Nine Months Ended June 30, 2022			Nine Months Ended June 30, 2021
	Three Months Ended June 30, 2022			Three Months Ended June 30, 2021			Nine Months Ended June 30, 2022			Nine Months Ended June 30, 2021
Revenues, net	$	774,019		$	510,032		$	2,508,345		$	1,442,083
Cost of sales		857,672			413,446			2,575,646			1,352,843
Gross profit (loss)		(83,653	)		96,586			(67,301	)		89,240

Operating expenses		2,546,608			3,165,840			8,554,276			15,103,252
Loss from operations		(2,630,261	)		(3,069,254	)		(8,621,577	)		(15,014,012	)

Loss from equity method investment		(1,919	)		(102	)		(4,215	)		(4,077	)
Other income		60,672			47,909			145,890			101,623
Other expense		(60,361	)		(41,992	)		(174,889	)		(120,978	)
Interest expense, net		(2,023	)		(3,603	)		(7,001	)		(11,278	)
Net loss	$	(2,633,892	)	$	(3,067,042	)	$	(8,661,792	)	$	(15,048,722	)
Basic and diluted loss per common share	$	(0.14	)	$	(0.17	)	$	(0.47	)	$	(0.94	)

Basic and diluted weighted average number of common stock outstanding		19,332,753			17,820,390			18,475,396			15,938,931

For the three months ended March 31	2022			2021
	NuZee, Inc.
For the three months ended March 31	2022			2021
							NuZee, Inc.
For the three months ended June 30							2022			2021
Net loss	$	(3,223,697	)	$	(6,085,608	)	$	(2,633,892	)	$	(3,067,042	)

Foreign currency translation		(7,095	)		3,824			(45,197	)		(7,854	)
Total other comprehensive (loss) income, net of tax		(7,095	)		3,824
Total other comprehensive loss, net of tax								(45,197	)		(7,854	)
Comprehensive loss	$	(3,230,792	)	$	(6,081,784	)	$	(2,679,089	)	$	(3,074,896	)

For the six months ended March 31	2022			2021
	NuZee, Inc.
For the six months ended March 31	2022			2021
Net loss	$	(6,027,900	)	$	(11,981,680	)

Foreign currency translation		25,593			5,480
Total other comprehensive income, net of tax		25,593			5,480
Total other comprehensive (loss) income, net of tax		25,593			5,480
Comprehensive loss	$	(6,002,307	)	$	(11,976,200	)


	NuZee, Inc.
For the nine months ended June 30	2022			2021
Net loss	$	(8,661,792	)	$	(15,048,722	)

Foreign currency translation		(19,604	)		(2,374	)
Total other comprehensive loss, net of tax		(19,604	)		(2,374	)
Total other comprehensive loss, net of tax		(19,604	)		(2,374	)
Comprehensive loss	$	(8,681,396	)	$	(15,051,096	)


											Accumulated
					Additional						other
	Common stock				paid-in			Accumulated			comprehensive
	Shares		Amount		capital			deficit			income			Total

Balance September 30, 2021		17,820,390	$	178	$	64,839,254		$	(52,824,808	)	$	197,823		$	12,212,447

Exercise of warrants, net of issuance costs		384,447		4		1,721,014			-			-			1,721,018
Stock option expense		-		-		1,124,187			-			-			1,124,187
Other comprehensive gain		-		-		-			-			32,688			32,688
Net loss		-		-		-			(2,804,203	)		-			(2,804,203	)
Balance December 31, 2021		18,204,837	$	182	$	67,684,455		$	(55,629,011	)	$	230,511		$	12,286,137

Warrant issuance costs		-		-		(18,422	)		-			-			(18,422	)
Common stock issued for cash, ATM offering, net of issuance costs		42,448		-		88,426			-			-			88,426
Common stock issued for Dripkit acquisition		178,681		2		386,842			-			-			386,844
Stock option expense		-		-		935,447			-			-			935,447
Exercise of stock options		14,000		-		12,600			-			-			12,600
Restricted stock award issuance		117,920		1		9,589			-			-			9,590
Other comprehensive loss		-		-		-			-			(7,095	)		(7,095	)
Net loss		-		-		-			(3,223,697	)		-			(3,223,697	)
Balance March 31, 2022		18,557,886		185	$	69,098,937		$	(58,852,708	)	$	223,416		$	10,469,830
Common stock issued for cash, ATM offering, net of issuance costs		6,878		-	$	6,830		$	-		$	-		$	6,830
Equity securities issued for cash, exempt offering, net of issuance costs		884,778		9		1,649,727			-			-			1,649,736

Common stock issued to settle Dripkit Bulk Sales Holdback Amount		18,475		-		40,000			-			-			40,000
Stock option expense		-		-		627,895			-			-			627,895
Amortization of restricted stock award issued		-		-		62,326			-			-			62,326
Other comprehensive loss		-		-		-			-			(45,197	)		(45,197	)
Net loss		-		-		-			(2,633,892	)		-			(2,633,892	)
Balance June 30, 2022		19,468,017	$	194	$	71,485,715		$	(61,486,600	)	$	178,219		$	10,177,528

										Accumulated
	Common stock				Additional paid-in		Accumulated			other comprehensive
	Shares		Amount		capital		deficit			income			Total

Balance September 30, 2020		14,570,105	$	146	$	40,472,229	$	(34,272,778	)	$	190,161		$	6,389,758
Equity securities issued for cash, net of issuance costs		324,959		3		2,683,977		-			-			2,683,980
Stock option expense		-		-		4,507,298		-			-			4,507,298
Exercise of stock options		6,000		-		9,180		-			-			9,180
Other comprehensive gain		-		-		-		-			1,656			1,656
Net loss		-		-		-		(5,896,072	)		-			(5,896,072	)
Balance December 31, 2020		14,901,064	$	149	$	47,672,684	$	(40,168,850	)	$	191,817		$	7,695,800
								-
Equity securities issued for cash, net of issuance costs		2,782,111		28		11,017,276		-			-			11,017,304
Restricted stock award issuance		137,215		1		870,999		-			-			871,000
Stock option expense		-		-		1,989,006		-			-			1,989,006
Other comprehensive gain		-		-		-		-			3,824			3,824
Net loss		-		-		-		(6,085,608	)					(6,085,608	)
Balance March 31, 2021		17,820,390		178	$	61,549,965	$	(46,254,458	)	$	195,641		$	15,491,326

Amortization of restricted stock award issued		-		-		91,036		-			-			91,036
Stock option expense		-		-		1,506,613		-			-			1,506,613
Other comprehensive loss		-		-		-		-			(7,854	)		(7,854	)
Net loss		-		-		-		(3,067,042	)		-			(3,067,042	)

Balance June 30, 2021		17,820,390		178	$	63,147,614	$	(49,321,500	)	$	187,787		$	14,014,079

							June 30, 2022			June 30, 2021
	Six Months Ended			Six Months Ended			Nine Months Ended			Nine Months Ended
	March 31, 2022			March 31, 2021			June 30, 2022			June 30, 2021

Operating activities:
Net loss	$	(6,027,900	)	$	(11,981,680	)	$	(8,661,792	)	$	(15,048,722	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization		166,161			161,911
Depreciation and amortization								295,178			254,929
Noncash lease expense		94,544			142,664			213,539			215,397
Stock option expense		2,059,634			6,496,304			2,687,529			8,002,917
Restricted stock award compensation		9,590			871,000
Restricted stock award issuance								71,916			962,036
Property and equipment impairment		-			840,391			-			840,391
Sales allowance		-			(2,003	)		-			(11,563	)
Loss on disposition of asset		12,618			-			12,618			-
Write-off of deferred offering costs		-			477,605			-			477,605
Loss from investment in unconsolidated affiliate		2,296			3,975
Loss from equity method investment								4,215			4,077
Change in operating assets and liabilities:
Accounts receivable		(91,648	)		(63,519	)		(18,752	)		(112,858	)
Inventories		(48,156	)		4,079			(99,452	)		(183,486	)
Prepaid expenses and other current assets		(432,286	)		50,448			(49,464	)		(141,018	)
Other assets		(25,527	)		(1,367	)		(6,926	)		(1,362	)
Accounts payable		398,464			(7,529	)		112,917			31,540
Deferred income		113,209			13,516			162,495			61,032
Lease liability – operating lease		(91,525	)		(127,811	)		(210,194	)		(193,118	)
Accrued expenses and other current liabilities		(305,129	)		200,805			(206,140	)		(363,112	)
Other non-current liabilities		11,627			730			15,015			728
Net cash used in operating activities		(4,154,028	)		(2,920,481	)		(5,677,298	)		(5,204,587	)

Investing activities:
Purchase of equipment		(165,689	)		(122,554	)		(214,524	)		(141,445	)
Acquisition of Dripkit		(373,832	)		-			(413,069	)		-
Net cash used in investing activities		(539,521	)		(122,554	)		(627,593	)		(141,445	)

Financing activities:
Proceeds from issuance of common stock, exercise of options		12,600			9,180			12,600			9,180
Repayment of loans		(28,047	)		(25,971	)		(41,671	)		(40,407	)
Repayment of finance lease		(11,870	)		(10,457	)		(18,094	)		(15,939	)
Stock issuance costs		-			(669,433	)
Proceeds from issuance of common stock, ATM offering		88,426			-
Proceeds from issuance of common stock, ATM offering, net of issuance costs								95,256				-
Proceeds from issuance of common stock, exercise of warrants, net of issuance costs		1,702,596			14,370,717			1,702,596			-
Advances received on sale of equity securities		300,000			-
Proceeds from issuance of equity securities, exempt offering, net of issuance costs								1,649,736			-
Proceeds from issuance of equity securities, net of issuance costs								-			13,701,284
Cash paid for offering costs								(368,783)			-
Net cash provided by financing activities		2,063,705			13,674,036			3,031,640			13,654,118

Effect of foreign exchange on cash		25,593			5,480			(19,604	)		(2,374	)

Net change in cash		(2,604,251	)		10,636,481			(3,292,855	)		8,305,712

Cash, beginning of period		10,815,954			4,398,545			10,815,954			4,398,545
Cash, end of period	$	8,211,703		$	15,035,026		$	7,523,099		$	12,704,257

Supplemental disclosure of cash flow information:
Cash paid for interest	$	5,390		$	7,792		$	7,077		$	11,278
Cash paid for taxes	$	-		$	1,050		$	800		$	7,044

Non-cash transactions:
ROU assets and liabilities added during the period	$	558,371		$	-		$	558,371		$	-
Common stock issued in acquisition of Dripkit	$	386,844		$	-		$	426,844		$	-
Stock issuance costs accrued	$	97,867		$	-		$	273,762		$	-

Customer Name	Sales Amount		% of Total Revenue			Accounts Receivable Amount		% of Total Accounts Receivable			Sales Amount		% of Total Revenue			Accounts Receivable Amount		% of Total Accounts Receivable
Customer WP	$	520,208		30	%	$	190,978		30	%	$	660,997		26	%	$	239,579		42	%
Customer CU	$	252,137		15	%	$	189,768		29	%	$	252,137		10	%	$	52,564		9	%
Customer S											$	242,580		10	%	$	62,590		11	%


ROU Asset – October 1, 2021	$	386,587		$	386,587
ROU Asset added during the period		558,371			558,371
Amortization during the period		(94,544	)		(213,539	)
ROU Asset –March 31, 2022	$	850,414
ROU Asset – June 30, 2022				$	731,419
Lease Liability – October 1, 2021	$	398,587		$	398,587
Lease Liability added during the period		558,371			558,371
Amortization during the period		(91,525	)		(210,194	)
Lease Liability – March 31, 2022	$	865,433
Lease Liability – June 30, 2022				$	746,764

Lease Liability – Short-Term	$	349,825		$	180,939
Lease Liability – Long-Term		515,608			565,825
Lease Liability – Total	$	865,433		$	746,764


2023	$	373,017
2024		343,295
2025		187,692
Total Minimum Lease Payments		904,004
Less Effect of Discounting		(38,571	)
Present Value of Future Minimum Lease Payments		865,433
Less Current Portion of Operating Lease Liabilities		349,825
Long-Term Operating Lease Liabilities	$	515,608


2023	$	292,775
2024		322,280
2025		186,759
Total Minimum Lease Payments		801,814
Less Effect of Discounting		(55,050	)
Present Value of Future Minimum Lease Payments		746,764
Less Current Portion of Operating Lease Liabilities		180,939
Long-Term Operating Lease Liabilities	$	565,825


2022	$	33,113		$	33,113
2023		33,113			33,113
2024		11,037			2,759
2025		-
2026		-
Total Minimum Lease Payments		77,263			68,985
Amount representing interest		(10,733	)		(8,679	)
Present Value of Minimum Lease Payments		66,530			60,306
Current Portion of Finance Lease Obligations		29,665			30,610
Finance Lease Obligations, Less Current Portion	$	36,865		$	29,696


Operating cash outflows from operating leases:	$	123,217	$	216,334
Operating cash outflows from finance lease:	$	4,686	$	6,741
Financing cash outflows from finance lease:	$	11,870	$	18,094


2023	$	125,104	$	126,017
2024		128,881		129,835
2025		32,458
2026		-
2027		-
Total	$	286,443	$	255,852

	Ford Motor Credit
2022 (Jul 2022 - Sep 2022)	$	1,951
2023 (Oct 2022 - Jun 2023)		5,939
Total Current Portion	$	7,890

2023 (Jul 2023 - Sep 2023)	$	6,753
Total Long-Term Portion	$	6,753

Grand Total	$	14,643

	Ford Motor Credit		ShinHan Bank		Total
2022 (Apr 2022 - Sep 2022)	$	3,888		4,619
2023 (Oct 2022 - Mar 2023)		3,945		7,067
Total Current Portion	$	7,833		11,686		19,519

2023 (Apr 2023 - Sep 2023)	$	8,748		-
Total Long-Term Portion	$	8,748		-		8,748
Grand Total	$	16,581		11,686		28,267

	March 31, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Raw materials	$	573,733	$	552,621	$	638,444	$	552,621
Finished goods		57,551		20,843		44,136		20,843
Less – Inventory reserve		-		-		-		-
Total	$	631,284	$	573,464	$	682,580	$	573,464

	Six Months Ended		Six Months Ended		Nine Months Ended		Nine Months Ended
	March 31, 2022		March 31, 2021		June 30, 2022		June 30, 2021
Net Revenue:
North America	$	1,401,285	$	658,338	$	2,031,781	$	1,077,986
South Korea		333,041		273,713		476,564		364,097
Net Revenue	$	1,734,326	$	932,051	$	2,508,345	$	1,442,083

Property and equipment, net:	As of March 31, 2022		As of September 30, 2021		As of June 30, 2022		As of September 30, 2021
North America	$	411,733	$	517,966	$	400,842	$	517,966
South Korea		257,969		154,562		209,254		154,562
Japan		2,943		1,496		2,200		1,496
Property and equipment, net	$	672,645	$	674,024	$	612,296	$	674,024

	March 31, 2022
Total purchase price	$	876,176	$	876,176
Assets acquired:
Inventory	$	9,664	$	9,664
Property and equipment		5,100		5,100
Identifiable intangible assets		330,000		330,000
Total assets acquired	$	344,764	$	344,764

Estimated fair value of net assets acquired	$	344,764	$	344,764
Goodwill	$	531,412	$	531,412

Description	2022		2021		2022		2021

	For the three months ended March 31,				For the six months ended March 31,				For the three months ended June 30,				For the nine months ended June 30,
Description	2022		2021		2022		2021		2022		2021		2022		2021
Revenues	$	772,165	$	511,591	$	1,811,693	$	1,155,526	$	774,019	$	631,744	$	2,585,802	$	1,787,270
Net loss	$	3,025,896	$	6,159,019	$	5,866,279	$	12,132,852	$	2,624,975	$	3,101,583	$	8,491,254	$	15,234,435

	March 31, 2022		June 30, 2022
Balance at September 30, 2021	$	-	$	-
Dripkit acquisition		531,412		531,412
Balance at March 31, 2022	$	531,412
Balance at June 30, 2022			$	531,412

	Amortization Period (Years)		March 31, 2022						Amortization		June 30, 2022
			Gross		Accumulated Amortization		Net		Period (Years)		Gross		Accumulated Amortization		Net
Tradenames		5	$	230,000	$	3,833	$	226,167		5	$	230,000	$	15,333	$	214,667
Customer relationships		3		100,000		2,778		97,222		3		100,000		11,111		88,889
Balance at March 31, 2022			$	330,000	$	6,611	$	323,389
Balance at June 30, 2022											$	330,000	$	26,444	$	303,556

	June 30, 2022
Risk-free interest rate		2.38	%
Expected option life		6 years
Expected volatility		70.53	%
Expected dividend yield		0.00	%
Exercise price	$	2.16

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value		Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value
Outstanding at September 30, 2021		4,511,691		$	4.73		8.4	$	452,206		4,511,691		$	4.73		8.4	$	452,206
Granted		-			-						100,000			2.16
Exercised		(14,000	)		0.90						(14,000	)		0.90
Expired		-			-						-			-
Forfeited		(203,166	)		13.75						(223,500	)		13.16
Outstanding at March 31, 2022		4,294,525		$	4.32		8.0	$	397,300
Exercisable at March 31, 2022		1,809,800		$	4.91		7.0	$	321,900
Outstanding at June 30, 2022											4,374,191		$	4.25		7.8	$	-
Exercisable at June 30, 2022											1,932,379		$	4.92		6.8	$	-

	Number of Nonvested Options			Weighted Average Grant Date Fair Value		Number of Nonvested Options			Weighted Average Grant Date Fair Value
Nonvested options at September 30, 2021		2,870,799		$	5.02		2,870,799		$	5.02
Granted		-			-		100,000			2.16
Forfeited		(36,500	)		3.89		(54,333	)		4.43
Vested		(349,574	)		5.95		(474,653	)		5.90
Nonvested options at March 31, 2022		2,484,725		$	4.90
Nonvested options at June 30, 2022							2,441,813		$	4.74

	Number of Shares Issuable Upon Exercise of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value		Number of Shares Issuable Upon Exercise of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value
Outstanding at September 30, 2021		4,831,915		$	4.98		4.5	$	-		4,831,915		$	4.98		4.5	$	-
Issued		-			-						884,778			2.00
Exercised		(384,447	)		4.51						(384,447	)		4.51
Expired		-			-						-			-
Outstanding at March 31, 2022		4,447,468		$	5.02		4.0		-
Exercisable at March 31, 2022		4,447,468		$	5.02		4.0	$	-
Outstanding at June 30, 2022											5,332,246		$	4.52		3.9		-
Exercisable at June 30, 2022											5,332,246		$	4.52		3.9	$	-